FDA approved drugs:
(show all 6)
| # |
|
Drug Name |
Active Ingredient(s) 18
|
Company |
Approval Date |
| 1 |
|
Adcirca
18
|
TADALAFIL |
Eli Lilly |
May 2009 |
Disease/s that Drug Treats:pulmonary arterial hypertension
Indications and Usage:
18
ADCIRCA is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability. Studies establishing effectiveness included predominately patients with NYHA Functional Class II - III symptoms and etiologies of idiopathic or heritable PAH (61%) or PAH associated with connective tissue diseases (23%). (1.1)
DrugBank Targets:
16
cGMP-specific 3',5'-cyclic phosphodiesterase|Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A
Mechanism of Action:
18
Target: phosphodiesterase type 5 (PDE5)
Action: oral inhibitor
FDA: Tadalafil is an inhibitor of phosphodiesterase type 5 (PDE5), the enzyme responsible for the degradation of cyclic guanosine monophosphate (cGMP). Pulmonary arterial hypertension is associated with impaired release of nitric oxide by the vascular endothelium and consequent reduction of cGMP concentrations in the pulmonary vascular smooth muscle. PDE5 is the predominant phosphodiesterase in the pulmonary vasculature. Inhibition of PDE5 by tadalafil increases the concentrations of cGMP resulting in relaxation of pulmonary vascular smooth muscle cells and vasodilation of the pulmonary vascular bed. Studies in vitro have demonstrated that tadalafil is a selective inhibitor of PDE5. PDE5 is found in pulmonary vascular smooth muscle, visceral smooth muscle, corpus cavernosum, skeletal muscle, platelets, kidney, lung, cerebellum, and pancreas.In vitro studies have shown that the effect of tadalafil is more potent on PDE5 than on other phosphodiesterases. These studies have shown that tadalafil is >10,000-fold more potent for PDE5 than for PDE1, PDE2, PDE4, and PDE7 enzymes, which are found in the heart, brain, blood vessels, liver, leukocytes, skeletal muscle, and other organs. Tadalafil is >10,000-fold more potent for PDE5 than for PDE3, an enzyme found in the heart and blood vessels. Additionally, tadalafil is 700-fold more potent for PDE5 than for PDE6, which is found in the retina and is responsible for phototransduction. Tadalafil is >9,000-fold more potent for PDE5 than for PDE8, PDE9, and PDE10. Tadalafil is 14-fold more potent for PDE5 than for PDE11A1 and 40-fold more potent for PDE5 than for PDE11A4, two of the four known forms of PDE11. PDE11 is an enzyme found in human prostate, testes, skeletal muscle and in other tissues. In vitro, tadalafil inhibits human recombinant PDE11A1 and, to a lesser degree, PDE11A4 activities at concentrations within the therapeutic range. The physiological role and clinical consequence of PDE11 inhibition in humans have not been defined.
|
| 2 |
|
Adempas
18
|
RIOCIGUAT |
Bayer Healthcare Pharmaceuticals |
October 2013 |
Disease/s that Drug Treats:Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension
Indications and Usage:
18
Adempas is a soluble guanylate cyclase (sGC) stimulator indicated for the treatment of adults with: * Persistent/recurrent Chronic Thromboembolic Pulmonary Hypertension (CTEPH) (WHO Group 4) after surgical treatment or inoperable CTEPH to improve exercise capacity and WHO functional class. (1.1) * Pulmonary Arterial Hypertension (PAH) (WHO Group 1) to improve exercise capacity, improve WHO functional class and to delay clinical worsening. (1.2)
DrugBank Targets:
-
Mechanism of Action:
18
Target: soluble guanylate cyclase (sGC)
Action: stimulator
FDA: Riociguat is a stimulator of soluble guanylate cyclase (sGC), an enzyme in the cardiopulmonary system and the receptor for nitric oxide (NO). When NO binds to sGC, the enzyme catalyzes synthesis of the signaling molecule cyclic guanosine monophosphate (cGMP). Intracellular cGMP plays an important role in regulating processes that influence vascular tone, proliferation, fibrosis and inflammation.Pulmonary hypertension is associated with endothelial dysfunction, impaired synthesis of nitric oxide and insufficient stimulation of the NO-sGC-cGMP pathway. Riociguat has a dual mode of action. It sensitizes sGC to endogenous NO by stabilizing the NO-sGC binding. Riociguat also directly stimulates sGC via a different binding site, independently of NO. Riociguat stimulates the NO-sGC-cGMP pathway and leads to increased generation of cGMP with subsequent vasodilation. The active metabolite (M1) of riociguat is 1/3 to 1/10 as potent as riociguat.
|
| 3 |
|
Covera-HS
18
|
VERAPAMIL HYDROCHLORIDE |
GD Searle, Alza |
January 1996 |
Disease/s that Drug Treats:hypertension, angina
Indications and Usage:
18
COVERA-HS is indicated for the management of hypertension and angina.
DrugBank Targets:
16
Voltage-dependent L-type calcium channel subunit alpha-1C|Voltage-dependent L-type calcium channel subunit alpha-1D|Voltage-dependent L-type calcium channel subunit alpha-1F|Voltage-dependent L-type calcium channel subunit alpha-1S|Voltage-dependent L-type calcium channel subunit beta-1|Voltage-dependent L-type calcium channel subunit beta-2|Voltage-dependent L-type calcium channel subunit beta-3|Voltage-dependent L-type calcium channel subunit beta-4|Voltage-dependent T-type calcium channel subunit alpha-1I|Voltage-dependent T-type calcium channel subunit alpha-1G|Voltage-dependent N-type calcium channel subunit alpha-1B|Voltage-dependent P/Q-type calcium channel subunit alpha-1A|Potassium voltage-gated channel subfamily H member 2|Sodium channel protein type 5 subunit alpha|ATP-sensitive inward rectifier potassium channel 11|Sodium-dependent serotonin transporter
Mechanism of Action:
18
Target: -
Action: -
FDA: In vitro: Verapamil binding is voltage-dependent with affinity increasing as the vascular smooth muscle membrane potential is reduced. In addition, verapamil binding is frequency dependent and apparent affinity increases with increased frequency of depolarizing stimulus. The L-type calcium channel is an oligomeric structure consisting of five putative subunits designated alpha-1, alpha-2, beta, tau, and epsilon. Biochemical evidence points to separate binding sites for 1,4-dihydropyridines, phenylalkylamines, and the benzothiazepines (all located on the alpha-1 subunit). Although they share a similar mechanism of action, calcium channel blockers represent three heterogeneous categories of drugs with differing vascular-cardiac selectivity ratios. Essential hypertension: Verapamil produces its antihypertensive effect by a combination of vascular and cardiac effects. It acts as a vasodilator with selectivity for the arterial portion of the peripheral vasculature. As a result, the systemic vascular resistance is reduced and usually without orthostatic hypotension or reflex tachycardia. Bradycardia (rate less than 50 beats/min) is uncommon (<1% with COVERA-HS as assessed by ECG). During isometric or dynamic exercise, COVERA-HS does not alter systolic cardiac function in patients with normal ventricular function. COVERA-HS does not alter total serum calcium levels. However, one report has suggested that calcium levels above the normal range may alter the therapeutic effect of verapamil. COVERA-HS regularly reduces the total systemic resistance (afterload) against which the heart works both at rest and at a given level of exercise by dilating peripheral arterioles. Effects in hypertension: COVERA-HS was evaluated in two placebo-controlled, parallel design, double-blind studies of 382 patients with mild to moderate hypertension. In a clinical trial, 287 patients were randomized to placebo, 120 mg, 180 mg, 360 mg, or 540 mg and treated for 8 weeks (the two higher doses were titrated from low doses and maintained for 6 and 4 weeks, respectively). COVERA-HS or placebo was given once daily at 10 pm and blood pressure changes were measured with 36-hour ambulatory blood pressure monitoring (ABPM). The results of these studies demonstrate that COVERA-HS, at 180-540 mg, is a consistently and significantly more effective antihypertensive agent than placebo in reducing ambulatory blood pressures. Over this dose range, the placebo-subtracted net decreases in diastolic BP at trough (averaged over 6-10 pm) were dose-related, ranged from 4.5 to 11.2 mm Hg after 4-8 weeks of therapy, and correlated well with sitting cuff blood pressures. These studies demonstrate that clinically and statistically significant blood pressure reductions are achieved with COVERA-HS throughout the 24-hour dosing period. There were no significant treatment differences between patient subgroups of different age (older or younger than 65 years), sex, race (Caucasian and non-Caucasian) and severity of hypertension at baseline (cuff BP below and above 105 mm Hg). Angina: Verapamil dilates the main coronary arteries and coronary arterioles, both in normal and ischemic regions, and is a potent inhibitor of coronary artery spasm, whether spontaneous or ergonovine-induced. This property increases myocardial oxygen delivery in patients with coronary artery spasm and is responsible for the effectiveness of verapamil in vasospastic (Prinzmetalâs or variant) as well as unstable angina at rest. Whether this effect plays any role in classical effort angina is not clear, but studies of exercise tolerance have not shown an increase in the maximum exercise rate-pressure product, a widely accepted measure of oxygen utilization. This suggests that, in general, relief of spasm or dilation of coronary arteries is not an important factor in classical angina. Verapamil regularly reduces the total systemic resistance (afterload) against which the heart works both at rest and at a given level of exercise by dilating peripheral arterioles. Effect in chronic stable angina: COVERA-HS was evaluated in two placebocontrolled, parallel design, double-blind studies of 453 patients with chronic stable angina. In the first clinical trial, 277 patients were randomized to placebo, 180 mg, 360 mg, or 540 mg and treated for 4 weeks (the two higher doses were titrated from low doses and maintained for 3 and 2 weeks, respectively). A single dose of 240 mg was compared toplacebo in a separate study of 176 patients. In these studies, COVERA-HS was significantly more effective than placebo in improvement of exercise tolerance. Placeboadjusted net increases in median exercise times at the end of the dosing interval were 0.1 to 1.0 minute for symptom limited duration, 0.3 to 1.4 minutes for time to angina, and 0.1 to 1.1 minutes for time to ST change. Increases in exercise tolerance were in general greater at higher doses, but dose-response relationship was not well defined due to shorter treatment duration for high doses. In addition, in the first study, 24% to 34% of patients treated with COVERA-HS did not experience exercise-limiting angina on exercise treadmill testing (ETT) versus 12% of patients on placebo. Electrophysiologic effects: Electrical activity through the AV node depends, to a significant degree, upon the transmembrane influx of extracellular calcium through the Ltype (slow) channel. By decreasing the influx of calcium, verapamil prolongs the effective refractory period within the AV node and slows AV conduction in a rate-related manner. Normal sinus rhythm is usually not affected, but in patients with sick sinus syndrome, verapamil may interfere with sinus-node impulse generation and may induce sinus arrest or sinoatrial block. Atrioventricular block can occur in patients without preexisting conduction defects (see WARNINGS). COVERA-HS does not alter the normal atrial action potential or intraventricular conduction time, but depresses amplitude, velocity of depolarization, and conduction in depressed atrial fibers. Verapamil may shorten the antegrade effective refractory period of the accessory bypass tract. Acceleration of ventricular rate and/or ventricular fibrillation has been reported in patients with atrial flutter or atrial fibrillation and a coexisting accessory AV pathway following administration of verapamil (see WARNINGS). Verapamil has a local anesthetic action that is 1.6 times that of procaine on an equimolar basis. It is not known whether this action is important at the doses used in man.
|
| 4 |
|
Letairis
18
|
AMBRISENTAN |
Gilead |
June 2007 |
Disease/s that Drug Treats:pulmonary arterial hypertension
Indications and Usage:
18
Letairis is an endothelin receptor antagonist indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1): * To improve exercise ability and delay clinical worsening. * In combination with tadalafil to reduce the risks of disease progression and hospitalization for worsening PAH, and to improve exercise ability. Studies establishing effectiveness included trials predominantly in patients with WHO Functional Class II-III symptoms and etiologies of idiopathic or heritable PAH (60%) or PAH associated with connective tissue diseases (34%) (1).
DrugBank Targets:
16
Endothelin-1 receptor|Endothelin B receptor
Mechanism of Action:
18
Target: endothelin receptor
Action: type-A selective antagonist
FDA: Endothelin-1 (ET-1) is a potent autocrine and paracrine peptide. Two receptor subtypes, ETA and ETB, mediate the effects of ET-1 in the vascular smooth muscle and endothelium. The primary actions of ETA are vasoconstriction and cell proliferation, while the predominant actions of ETB are vasodilation, antiproliferation, and ET-1 clearance. In patients with PAH, plasma ET-1 concentrations are increased as much as 10-fold and correlate with increased mean right atrial pressure and disease severity. ET-1 and ET-1 mRNA concentrations are increased as much as 9-fold in the lung tissue of patients with PAH, primarily in the endothelium of pulmonary arteries. These findings suggest that ET-1 may play a critical role in the pathogenesis and progression of PAH. Ambrisentan is a high-affinity (Ki=0.011 nM) ETA receptor antagonist with a high selectivity for the ETA versus ETB receptor (>4000-fold). The clinical impact of high selectivity for ETA is not known.
|
| 5 |
|
Opsumit
18
|
MACITENTAN |
Actelion Pharmaceuticals |
October 2013 |
Disease/s that Drug Treats:pulmonary arterial hypertension
Indications and Usage:
18
OPSUMIT is an endothelin receptor antagonist (ERA) indicated for the treatment of pulmonary arterial hypertension (PAH, WHO Group I) to delay disease progression. Disease progression included: death, initiation of intravenous (IV) or subcutaneous prostanoids, or clinical worsening of PAH (decreased 6-minute walk distance, worsened PAH symptoms and need for additional PAH treatment). OPSUMIT also reduced hospitalization for PAH (1.1).
DrugBank Targets:
16
Endothelin-1 receptor|Endothelin B receptor
Mechanism of Action:
18
Target: Endothelin Receptor
Action: antagonist
FDA: Endothelin (ET)-1 and its receptors (ETA and ETB) mediate a variety of deleterious effects, such as vasoconstriction, fibrosis, proliferation, hypertrophy, and inflammation. In disease conditions such as PAH, the local ET system is upregulated and is involved in vascular hypertrophy and in organ damage. Macitentan is an endothelin receptor antagonist that prevents the binding of ET-1 to both ETA and ETB receptors. Macitentan displays high affinity and sustained occupancy of the ET receptors in human pulmonary arterial smooth muscle cells. One of the metabolites of macitentan is also pharmacologically active at the ET receptors and is estimated to be about 20% as potent as the parent drug in vitro.
|
| 6 |
|
Remodulin
18
|
TREPROSTINIL |
United Therapeutics |
May 2002 |
Disease/s that Drug Treats:pulmonary arterial hypertension
Indications and Usage:
18
Remodulin is a prostacyclin vasodilator indicated for: * Treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to diminish symptoms associated with exercise. Studies establishing effectiveness included patients with NYHA Functional Class II-IV symptoms and etiologies of idiopathic or heritable PAH (58%), PAH associated with congenital systemic-to-pulmonary shunts (23%), or PAH associated with connective tissue diseases (19%) (1.1) * Patients who require transition from Flolan®, to reduce the rate of clinical deterioration. The risks and benefits of each drug should be carefully considered prior to transition. (1.2)
DrugBank Targets:
16
Prostacyclin receptor|Peroxisome proliferator-activated receptor delta|P2Y purinoceptor 12
Mechanism of Action:
18
Target: pulmonary and systemic arterial vascular beds|platelet aggregation
Action: direct vasodilation|inhibition
FDA: The major pharmacologic actions of treprostinil are direct vasodilation of pulmonary and systemic arterial vascular beds, and inhibition of platelet aggregation.
|
Drugs for Hypertension, Essential (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 261)
| # |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
| 1 |
|
Ramipril |
Approved |
Phase 4,Phase 3 |
|
87333-19-5 |
5362129
|
|
Synonyms:
(2 S ,3 aS ,6 aS )-1[( S )-N-[( S )-1-Carboxy-3-phenylpropyl] alanyl] octahydrocyclopenta [ b ]pyrrole-2-carboxylic acid, 1-ethyl ester
(2S-(1(R*(r*)),2a,3abeta,6abeta))-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylate
(2S-(1(R*(r*)),2a,3abeta,6abeta))-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid
(2S-(1(R*(r*)),2alpha,3abeta,6abeta))-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylate
(2S-(1(R*(r*)),2alpha,3abeta,6abeta))-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid
(2S-(1(R*(R*)),2alpha,3abeta,6abeta))-1-(2-((1-(Ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid.
(2S-(1(R*(r*)),2α,3abeta,6abeta))-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylate
(2S-(1(R*(r*)),2α,3abeta,6abeta))-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid
(2S,3aS,6aS)-1-((S)-2-((S)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl) octahydrocyclopenta[b]pyrrole-2-carboxylic acid
(2s,3as,6as)-1-((s)-2-((s)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl)-octahydrocyclopenta[b]p
(2s,3as,6as)-1((s)-n-((s)-1-carboxy-3-phenylpropyl)alanyl)octahydrocyclopenta(b)pyrrole-2-carboxylic
(2S,3aS,6aS)-1-((S)-N-((S)-1-Carboxy-3-phenylpropyl)alanyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid, 1-ethyl ester
(2S,3aS,6aS)-1-((S)-N-((S)-1-Ethoxycarbonyl-3-phenylpropyl)alanyl)octahydrocyclopenta(b)pyrrol-2-carbonsaeure
(2S,3aS,6aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid
(2S,3aS,6aS)-1-[(2S)-2-{[(1S)-1-ethoxycarbonyl-3-phenylpropyl]amino}propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid
(2S,3aS,6aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid (non-preferred name)
(2s,3as,6as)-1-[(s)-2-((s)-1-ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-octahydro-cyclopenta[b]
[2s,3as,6as]-1-[(2s)-2-[[(1s)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydrocyclopen
[2S,3aS,6aS]-1-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid
126613-39-6
87333-19-5
AC-1347
AC1NSFPR
Acovil
Almirall brand OF ramipril
Almirall Brand of Ramipril
Altace
Altace (tn)
Altace (TN)
Astra brand OF ramipril
Astra Brand of Ramipril
AstraZeneca brand OF ramipril
AstraZeneca Brand of Ramipril
Aventis brand OF ramipril
Aventis Brand of Ramipril
Aventis pharma brand OF ramipril
Aventis Pharma Brand of Ramipril
BIDD:GT0803
Bio-0651
BSPBio_003347
C23H32N2O5
Carasel
Cardace
CHEBI:289203
CHEBI:8774
CHEMBL1168
CID5362129
CPD000466386
D00421
D017257
DB00178
Delix
HMS2051E04
HMS2090L11
HMS2093M10
|
HOE 498
Hoe-498
HOE498
HOE-498
Hoechst brand OF ramipril
Hoechst Brand of Ramipril
Hypren
Hytren
KBio2_002504
KBio2_005072
KBio2_007640
KBio3_002849
KBioGR_001858
KBioSS_002512
Lostapres
LS-58199
MLS000759523
MLS001216547
MLS001423965
MolPort-001-736-571
Monarch brand OF ramipril
Monarch Brand of Ramipril
N-(1S-carboethoxy-3-phenylpropyl)-S-alanyl-cis,endo-2-azabicyclo[3.3.0]octane-3S-carboxylic Acid
Naprix
NCGC00178127-01
Pramace
Pramace (discontinued)
Promed brand OF ramipril
Promed Brand of Ramipril
Quark
R0404_SIGMA
Ramace
ramipril
Ramipril
Ramipril (USP/INN)
Ramipril [USAN:INN:BAN]
Ramiprilum
Ramiprilum [Latin]
Ramipro, Tritace, Altace, Prilace, Ramipril
S1793_Selleck
SAM001246757
SAM002699899
SMR000466386
Spectrum_001958
SPECTRUM1505214
Spectrum3_001794
Spectrum4_001269
Spectrum5_001721
STK801937
Triatec
Tritace
UNII-L35JN3I7SJ
Unipril
Vesdil
Zabien
|
|
| 2 |
|
Angiotensin II |
Approved, Investigational |
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
68521-88-0, 4474-91-3, 11128-99-7 |
172198
65143
|
|
Synonyms:
1-8-Angiotensin I
1-L-Aspasaginyl-5-L-valyl angiotensin octapeptide
5 L Isoleucine angiotensin II
5-isoleucine-angiotensin II
5-Isoleucine-angiotensin II
5-L-Isoleucine angiotensin II
5-L-isoleucineangiotensin II
5-L-Isoleucineangiotensin II
Ang II
ANG-(1-8)octapeptide
Angiotensin
Angiotensin 2
Angiotensin II (human)
Angiotensin II (mouse)
Angiotensin II, 5-L-isoleucine
Angiotensin-(1-8) octapeptide
|
Angiotonin
Asp-arg-val-tyr-ile-his-pro-phe
Human angiotensin II
Hypertensin
II, 5-L-isoleucine angiotensin
Ile(5)-angiotensin II
Ile5-angiotensin II
Isoleucine(5)-angiotensin
Isoleucine(5)-angiotensin II
isoleucine5-angiotensin II
Isoleucyl(5)-angiotensin II
N-(1-(N-(N-(N-(N-(N(2)-L-a-Aspartyl-L-arginyl)-L-valyl)-L-tyrosyl)-L-isoleucyl)-L-histidyl)-L-prolyl)-L-phenylalanine
N-(1-(N-(N-(N-(N-(N(2)-L-alpha-Aspartyl-L-arginyl)-L-valyl)-L-tyrosyl)-L-isoleucyl)-L-histidyl)-L-prolyl)-L-phenylalanine
N-(1-(N-(N-(N-(N-(N(2)-L-α-aspartyl-L-arginyl)-L-valyl)-L-tyrosyl)-L-isoleucyl)-L-histidyl)-L-prolyl)-L-phenylalanine
Valyl(5)-angiotensin II
|
|
| 3 |
|
Candesartan cilexetil |
Approved |
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
145040-37-5 |
2540
|
|
Synonyms:
(+-)-1-Hydroxyethyl 2-ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylate, cyclohexyl carbonate (ester)
1-(cyclohexylocarbonyloxy)ethyl-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)-1H-benzimidazole-7-carboxylate
1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-(ethyloxy)-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate
145040-37-5
1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester
2-ethoxy-3-[2'-(1h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3h-benzoimidazole-4-carboxylic acid 1-cyclohe
2-Ethoxy-3-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid 1-cyclohexyloxycarbonyloxy-ethyl ester
AC1L1DWQ
AC-204
Almirall brand of candesartan cilexetil
Amias
Astra brand of candesartan cilexetil
AstraZeneca brand of candesartan cilexetil
Atacand
Atacand (TN)
ATACAND HCT
BRD-A65671304-001-02-6
BSPBio_002691
C07709
C077793
C33H34N6O6
Candesartan cilexetil
Candesartan cilexetil (JAN/USAN)
Candesartan cilexetil [USAN]
candesartan cilexitil
Candesartan hexetil
CHEBI:216349
CHEMBL1014
CID2540
D00626
FT-0082579
H212/91
|
HMS1922J09
HMS2093E20
I06-0090
KBio2_002187
KBio2_004755
KBio2_007323
KBio3_001911
KBioGR_001607
KBioSS_002187
Kenzen
L006257
LS-32741
MolPort-003-666-552
NCGC00095123-01
NCGC00095123-02
NCGC00095123-03
Parapres
Promed brand of candesartan cilexetil
Racanda
SPBio_000349
Spectrum_001707
SPECTRUM1504261
Spectrum2_000485
Spectrum3_000996
Spectrum4_001124
Spectrum5_001462
ST51052687
Takeda brand of candesartan cilexetil
TCV 116
TCV-116
TL8000995
UNII-R85M2X0D68
|
|
| 4 |
|
Nifedipine |
Approved |
Phase 4,Phase 3,Phase 2,Phase 1 |
|
21829-25-4 |
4485
|
|
Synonyms:
101539-70-2
101554-38-5
21829-25-4
4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsaeuredimethylester
5-22-04-00268 (Beilstein Handbook Reference)
60299-11-8 (mono-hydrochloride)
AC-11618
AC1L1I9V
AC1Q4254
Adalat
Adalat (TN)
Adalat 10
Adalat 20
Adalat 5
Adalat CC
Adalat CR
Adalat Crono
Adalat Ft
Adalat FT
Adalat Gits
Adalat GITS
Adalat Gits 30
Adalat GITS 30
Adalat LA
Adalat LP
Adalat Oros
Adalat PA
Adalat Retard
Adalat XL
Adalate
Adalate LP
Adapine
Adapress
Adcock ingram brand OF nifedipine
Adcock Ingram Brand of Nifedipine
Adipine XL
Afeditab
Afeditab CR
Afeditab CR (TN)
AKOS002942507
Alat
Aldipin
Alfadal
Alonix
Alonix S
Alpha-Nifedipine Retard
Angipec
Anifed
Anpine
Apo-Nifed
Aprical
Aprical long
ARONIS24171
AWD pharma brand OF nifedipine
AWD Pharma Brand of Nifedipine
BAY 1040
BAY a 1040
BAY A 1040
Bay1040
Bay-1040
BAY-a 1040
Bay-a-1040
BAYa1040
BAY-a-1040
Bayer brand OF nifedipine
Bayer Brand of Nifedipine
BCBcMAP01_000046
BIDD:GT0442
BIDD:PXR0034
BIM-0050796.0001
Bio-0733
Bio1_000112
Bio1_000601
Bio1_001090
Bio2_000111
Bio2_000591
Bonacid
BPBio1_000271
BRN 0497773
BSPBio_000245
BSPBio_001391
BSPBio_002071
C07266
C17H18N2O6
Calcibloc
Calcigard
Calcilat
Camont
Cardifen
Cardilat
Cardionorm
CAS-21829-25-4
CBiol_001826
CCRIS 6074
CHEBI:7565
CHEMBL193
Chronadalate
Chronadalate Lp
Chronadalate LP
CID4485
Citilat
cMAP_000042
Coracten
Coracten XL
Coral
Cordafen
Cordaflex
Cordalat
Cordicant
Cordilan
Cordipin
Cordipine
Corinfar
Corotrend
Corynphar
CPD000058291
D00437
D009543
DB01115
Depin
Dignokonstant
Dilafed
Dilcor
Dipinkor
DivK1c_000313
Duranifin
Ecodipi
Ecodipin
Ecodipin E
EINECS 244-598-3
Emaberin
EU-0100819
Fedcor
Fedcor Retard
Fenamon
Fenamon Sr
Fenamon SR
Fenigidin
Fenihidin
Fenihidine
Fortipine LA
Glopir
Hadipin
Hexadilat
HMS1361F13
HMS1568M07
HMS1791F13
HMS1920P19
HMS1989F13
HMS2051O03
HMS2089H11
HMS2091H20
HMS500P15
|
I06-0051
I06-1286
IDI1_000313
IDI1_033861
Infedipin
Introcar
KB-1712P
KBio1_000313
KBio2_000111
KBio2_001459
KBio2_002400
KBio2_002679
KBio2_004027
KBio2_004968
KBio2_005247
KBio2_006595
KBio2_007536
KBio3_000221
KBio3_000222
KBio3_001571
KBio3_002879
KBioGR_000111
KBioGR_000627
KBioGR_002400
KBioSS_000111
KBioSS_001459
KBioSS_002405
Kordafen
Korinfar
KRKA brand OF nifedipine
KRKA Brand of Nifedipine
L001054
Lopac0_000819
Lopac-N-7634
LS-1012
Macorel
Megalat
MLS000028521
MLS000758222
MLS001148146
MLS001401371
MolPort-000-787-707
MolPort-006-822-492
Monohydrochloride, nifedipine
Monohydrochloride, Nifedipine
Myogard
N 7634
N0528
N1fedilat
N7634_SIGMA
NCGC00015748-01
NCGC00015748-02
NCGC00015748-03
NCGC00015748-06
NCGC00015748-13
NCGC00024983-01
NCGC00024983-02
NCGC00024983-03
NCGC00024983-04
NCGC00024983-05
NCGC00024983-06
NCGC00024983-07
NCGC00024983-08
NCGC00091707-01
nchembio.95-comp13
Nedipin
Nicardia
Nifangin
Nifar
Nifdemin
Nifebene
Nifecard
Nifecor
Nifedepat
Nifediac
Nifedical
Nifedical XL
Nifedicor
Nifedin
Nifedine
nifedipine
Nifedipine
Nifedipine (JP15/USP/INN)
Nifedipine [USAN:BAN:INN:JAN]
Nifedipine bayer brand
Nifedipine Bayer Brand
Nifedipine gtis
Nifedipine GTIS
Nifedipine krka brand
Nifedipine KRKA Brand
Nifedipine monohydrochloride
Nifedipine Monohydrochloride
Nifedipine orion brand
Nifedipine Orion Brand
Nifedipine pfizer brand
Nifedipine Pfizer Brand
Nifedipine Retard
Nifedipine-gtis
Nifedipine-GTIS
Nifedipino
Nifedipino [INN-Spanish]
Nifedipinum
Nifedipinum [INN-Latin]
Nifedipres
Nifedirex LP
Nifelan
Nifelat
Nifelat Q
Nifelate
Nifensar XL
Nificard
Nifidine
Nifipen
NINDS_000313
Niphedipine
Oprea1_788617
Orion brand OF nifedipine
Orion Brand of Nifedipine
Orix
Oxcord
Pfizer brand OF nifedipine
Pfizer Brand of Nifedipine
Pidilat
Prestwick_357
Prestwick0_000063
Prestwick1_000063
Prestwick2_000063
Prestwick3_000063
Procardia
Procardia (TN)
Procardia XL
S1808_Selleck
SAM001246963
Sepamit
Slofedipine XL
SMR000058291
SPBio_001016
SPBio_002166
Spectrum_000979
SPECTRUM1500431
Spectrum2_001058
Spectrum3_000516
Spectrum4_000074
Spectrum5_001278
STK735567
Tensipine MR
Tibricol
Tocris-1075
UNII-I9ZF7L6G2L
Vascard
Zenusin
ZINC19594578
|
|
| 5 |
|
Bisoprolol |
Approved |
Phase 4 |
|
66722-44-9 |
2405
|
|
Synonyms:
(+-)-1-((a-(2-Isopropoxyethoxy)-P-tolyl)oxy)-3-(isopropylamino)-2-propanol
(+-)-1-((alpha-(2-Isopropoxyethoxy)-p-tolyl)oxy)-3-(isopropylamino)-2-propanol
(+-)-1-((alpha-(2-Isopropoxyethoxy)-P-tolyl)oxy)-3-(isopropylamino)-2-propanol
(+-)-1-((α-(2-isopropoxyethoxy)-P-tolyl)oxy)-3-(isopropylamino)-2-propanol
(RS)-1-(4-(2-isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol
(RS)-1-(4-(2-Isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol
1-(propan-2-ylamino)-3-[4-(2-propan-2-yloxyethoxymethyl)phenoxy]propan-2-ol
1-[(1-methylethyl)amino]-3-({4-[({2-[(1-methylethyl)oxy]ethyl}oxy)methyl]phenyl}oxy)propan-2-ol
1-{4-[(2-isopropoxyethoxy)methyl]phenoxy}-3-(isopropylamino)propan-2-ol
66722-44-9
AB00514681
AC-18540
AC1L1DLQ
AKOS005110983
ARONIS24082
Bisocor
Bisoprolol
BISOPROLOL
Bisoprolol (USAN/INN)
Bisoprolol [USAN:BAN:INN]
Bisoprolol fumarate
Bisoprolol Fumarate
Bisoprolol fumarate (1:1) salt, (+-)-isomer
Bisoprolol fumarate (2:1) salt, (+-)-isomer
Bisoprolol fumerate
Bisoprolol hemifumarate
Bisoprolol Hemifumarate
Bisoprolol hydrochloride
Bisoprolol methanesulfonate salt
Bisoprolol, (-)-isomer
Bisoprolol, (+-)-isomer
Bisoprolol, fumarate (1:1) salt
Bisoprolol, fumarate (2:1) salt
Bisoprololum
Bisoprololum [Latin]
BPBio1_000373
BSPBio_000339
C06852
C18H31NO4
|
Cardicor
CHEBI:3127
CHEMBL645
CID2405
CL-297939
Concor
Condyline
Condylox
D02342
DB00612
Detensiel
Emconcor
Emcor
EMD-33512
EMD-33-512
Euradal
Fumarate, bisoprolol
Hydrochloride, bisoprolol
I01-7040
Isoten
L000133
LS-122509
Merck brand OF bisoprolol fumarate
MolPort-005-937-320
Monocor
NCGC00024868-02
NCGC00024868-03
NCGC00024868-04
NCGC00024868-05
Prestwick0_000330
Prestwick1_000330
Prestwick2_000330
Prestwick3_000330
SBB065120
Soloc
Soprol
SPBio_002260
UNII-Y41JS2NL6U
Zebeta
|
|
| 6 |
|
Amiloride |
Approved |
Phase 4,Not Applicable |
|
2016-88-8, 2609-46-3 |
16231
|
|
Synonyms:
17440-83-4 (hydrochloride)
1f5l
2016-88-8 (anhydrous hydrochloride)
2609-46-3
3,5-diamino-6-chloro-N-(diaminomethylidene)pyrazine-2-carboxamide
3,5-Diamino-N-(aminoiminomethyl)-6-chloropyrazinecarboxamide
3,5-diamino-N-[amino(imino)methyl]-6-chloropyrazine-2-carboxamide
3,5-diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide
3,5-diamino-N-Carbamimidoyl-6-chloropyrazine-2-carboxamide
3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide
AB00053415
AC-13631
AC1L27IZ
AC1Q3POC
Alphapharm brand OF amiloride hydrochloride
Amiclaran
Amiclaran (TN)
Amidal
Amiduret trom
Amikal (Hydrochloride dihydrate)
Amiloberag
Amilorid
Amilorida
Amilorida [INN-Spanish]
AMILORIDE
Amiloride (INN)
AMILORIDE (SEE ALSO: AMILORIDE HCL (2016-88-8))
Amiloride [INN:BAN]
Amiloride HCL
Amiloride hydrochloride
Amiloride hydrochloride hydrate
Amiloride hydrochloride, anhydrous
Amiloridum
Amiloridum [INN-Latin]
Amipramidin
Amipramidine
Amipramizid
Amipramizide
Amiprazidine
Amrad brand OF amiloride hydrochloride
Amyloride
Anhydrous amiloride hydrochloride
BCBcMAP01_000101
Berolina brand OF amiloride hydrochloride
BIDD:GT0466
Bio1_000359
Bio1_000848
Bio1_001337
Bio2_000292
Bio2_000772
BPBio1_000015
BRD-K97181089-003-02-3
BRD-K97181089-310-03-0
BSPBio_000013
BSPBio_001572
BSPBio_001826
C06821
C6H8ClN7O
Cahill may roberts brand OF amiloride hydrochloride
CCRIS 6545
CHEBI:2639
CHEMBL945
CID16231
CPD-10324
D07447
DB00594
DivK1c_000182
Douglas brand OF amiloride hydrochloride
EINECS 220-024-7
Guanamprazin
|
Guanamprazine
HMS1791O14
HMS1989O14
HMS2089H05
Hydrochloride, amiloride
Hydrochloride, anhydrous amiloride
IDI1_000182
IDI1_034042
Kaluril
KBio1_000182
KBio2_000292
KBio2_000394
KBio2_002860
KBio2_002962
KBio2_005428
KBio2_005530
KBio3_000583
KBio3_000584
KBio3_001326
KBioGR_000292
KBioGR_000544
KBioSS_000292
KBioSS_000394
Lopac0_000111
Lopac-A-7410
LS-1094
Merck brand OF amiloride hydrochloride
Merck sharp and dohme brand OF amiloride hydrochloride
Midamor
Midamor (Hydrochloride dihydrate)
Midoride
MK-870 (Hydrochloride dihydrate)
MLS000758249
MLS001060798
Modamide
MolPort-005-934-472
MolPort-005-937-651
N-amidino-3,5-diamino-6-chloropyrazinecarboxamide
N-amidino-3,5-diamino-6-Chloropyrazinecarboxamide
N-Amidino-3,5-diamino-6-chloropyrazinecarboxamide
N-Amidino-3,5-diamino-6-chlorpyrazincarboxamid
NCGC00015089-01
NCGC00015089-02
NCGC00015089-12
NCGC00024443-02
NCGC00024443-05
NCGC00024443-06
NCGC00024443-07
NCGC00024443-09
NINDS_000182
Prestwick0_000007
Prestwick1_000007
Prestwick2_000007
Prestwick3_000007
Pyrazinecarboxamide, 3,5-diamino-N-(aminoiminomethyl)-6-chloro-, monohydrochloride
SMR000449325
SMR000486264
SPBio_000136
SPBio_001934
Spectrum_000034
Spectrum2_000118
Spectrum3_000293
Spectrum4_000132
Spectrum5_000776
ST079279
Tocris-0890
Trom, amiduret
Trommsdorff brand OF amiloride hydrochloride
UNII-7DZO8EB0Z3
ZINC04340269
|
|
| 7 |
|
Amlodipine |
Approved |
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
88150-42-9 |
2162
|
|
Synonyms:
()-Amlodipine
(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
2-[(2-Aminoethoxy)methyl]-4-(2-chlorophenyl)
-3-(ethoxycarbonyl)-5-(methoxycarbonyl)-6-methyl-1,4-dihydropyridine
3,5-Pyridinedicarboxylic acid, 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester
3,5-Pyridinedicarboxylic acid, 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester
3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
3-ethyl 5-methyl 2-{[(2-aminoethyl)oxy]methyl}-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
3-Ethyl 5-methylester, (±)-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl ( -)-2-((2-aminoethoxy)methyl)-4-(2-chlorphenyl)-1,4-dihydro-6-methyl-3,5-pyridindicarboxylat
3-Ethyl-5-methyl ( -)-2-((2-aminoethoxymethyl)-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl (.+/-.)-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylic acid
3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
88150-42-9
88150-47-4 (maleate (1:1))
AC1L1D26
AC1Q32ZS
AC-4535
Almirall brand OF amlodipine besilate
Ambap88150-42-9
Amlocard
amlodipine
Amlodipine
Amlodipine (INN)
Amlodipine [INN:BAN]
AMLODIPINE BASE
Amlodipine Benzenesulfonate
Amlodipine besilate
Amlodipine Besilate
Amlodipine besylate
Amlodipine Besylate
Amlodipine free base
Amlodipine Free Base
Amlodipine maleate
Amlodipine maleate (1:1)
Amlodipine, (+-)-isomer
Amlodipine, (+-)-isomer, maleate (1:1)
Amlodipine, (R)-isomer
Amlodipine, (S)-isomer, maleate (1:1)
Amlodipino
Amlodipino [Spanish]
Amlodipinum
Amlodipinum [Latin]
Amlodis
Amlopres
Amlor
|
Amvaz
AMVAZ
Astudal
BIDD:GT0810
BRD-A22032524-074-02-4
BRD-A22032524-074-03-2
BSPBio_002727
C06825
CHEBI:2668
CHEMBL1491
CID2162
Coroval
CPD000469198
D07450
DB00381
Eczacibasi brand OF amlodipine besilate
HMS2052N03
HMS2089H07
I14-0798
Intervask
Istin
KBio3_001947
KBioGR_001643
Lipinox
Lotrel
LS-131183
Mack brand OF amlodipine besilate
MLS001401409
MolPort-001-792-963
NCGC00165957-01
NCGC00165957-02
NCGC00165957-03
Norvasc
Norvasc (TN)
Pelmec
Pfizer brand OF amlodipine besilate
R,S)-Amlodipine
Racemic amlodipine
Racemic Amlodipine
SAM001246705
SMR000469198
SPBio_000351
Spectrum2_000486
Spectrum3_001004
Spectrum4_001132
Spectrum5_001550
UK-4834011
UNII-1J444QC288
|
|
| 8 |
|
Simvastatin |
Approved |
Phase 4,Phase 3 |
|
79902-63-9 |
54454
|
|
Synonyms:
(+)-Simvastatin
(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate
[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate
2,2-Dimethylbutanoic acid (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester
2,2-Dimethylbutyrate, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one
2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one
2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one
79902-63-9
AC-1530
AC1L1H1F
AKOS005111006
ARONIS24119
BCBcMAP01_000007
BIDD:GT0769
Bio-0672
BPBio1_001001
BRD-K22134346-001-05-8
BRN 4768037
BSPBio_000909
BSPBio_002337
Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,*aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester
Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester
Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester
butanoic acid, 2,2-dimethyl-,1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)-ethyl]-1-naphthalenyl ester, [1S-[1 alpha,3 alpha,7 beta,8 beta(2S*,4S*),-8a beta
C25H38O5
CCRIS 7558
CHEBI:9150
CHEMBL1064
Cholestat
CID54454
Coledis
Colemin
Corolin
CPD000718785
D00434
D019821
Denan
DivK1c_006991
DRG-0320
Eucor
HMS1570N11
HMS1922H13
HMS2089D12
HMS2093E06
HSDB 7208
InChI=1/C25H38O5/c1-6-25(4,5)24(28)30-21-12-15(2)11-17-8-7-16(3)20(23(17)21)10-9-19-13-18(26)14-22(27)29-19/h7-8,11,15-16,18-21,23,26H,6,9-10,12-14H2,1-5H3/t15-,16-,18+,19+,20-,21-,23-/m0/s1
KBio1_001935
KBio2_002197
KBio2_004765
KBio2_007333
KBio3_001557
KBioGR_001244
KBioSS_002197
Kolestevan
KS-1113
L 644128-000U
Labistatin
Lipex
Lipinorm
Liponorm
Lipovas
Lodales
LS-46264
Medipo
MK 0733
MK 733
MK-0733
MK733
MK-733
MLS001304029
|
MLS001333077
MLS001333078
MLS002154038
Modutrol
MolPort-002-507-345
MolPort-002-885-862
NCGC00017324-01
NCGC00017324-02
NCGC00017324-03
nchembio790-comp16
Nivelipol
Nor-vastina
Pantok
Pepstatin
Prestwick_171
Prestwick0_000865
Prestwick1_000865
Prestwick2_000865
Prestwick3_000865
Rechol
Rendapid
S1792_Selleck
S6196_SIGMA
SAM002589969
Simcor
Simovil
Simvast CR
simvastatin
Simvastatin
Simvastatin & Primycin
Simvastatin (JAN/USP/INN)
Simvastatin [Usan:Ban:Inn]
Simvastatin [USAN:INN:BAN]
Simvastatin lactone
Simvastatin, Compactin
Simvastatina
Simvastatina [Spanish]
Simvastatine
Simvastatine [French]
Simvastatinum
Simvastatinum [Latin]
Simvotin
Sinvacor
Sinvascor
Sivastin
SMR000718785
SPBio_001881
SPBio_002830
SpecPlus_000895
Spectrum_001717
SPECTRUM1504236
Spectrum2_001671
Spectrum3_000669
Spectrum4_000632
Spectrum5_001428
Statin
STK801938
Synvinolin
TNP00259
UNII-AGG2FN16EV
Valemia
Vasotenal
Velostatin
Vytorin
ZINC03780893
Zocor
Zocor (TN)
Zocor, Simlup, Simcard, Simvacor, Simvoget, Zorced, Simvastatin
Zocord
|
|
| 9 |
|
Telmisartan |
Approved, Investigational |
Phase 4,Phase 3,Phase 2,Phase 1 |
|
144701-48-4 |
65999
|
|
Synonyms:
144701-48-4
2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid
4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylate
4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid
4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid
4'-((4-mehtyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimmidazolyl)methyl)-2-biphenylcarboxylic acid
4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylate
4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid
4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylate
4'-[(1,4'-dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid
4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid
4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl][1,1'-biphenyl]-2-carboxylic acid
4'-[(1,7'-Dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylate
4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid
4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid
4'-[(1,7'-Dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid
Abbott brand of telmisartan
AC1L24EB
AC1Q5U7O
AC-2013
Bay 68-9291
BAY68-9291
BAY-68-9291
BIBR 277
BIBR 277Se
BIBR 277SE
BIBR-277
BIBR-277SE
BIBR-277-SE
BIDD:GT0365
Bio-0103
Boehringer Ingelheim brand of telmisartan
BRD-K73999723-001-02-2
BSPBio_002738
C07710
C084178
C33H30N4O2
CHEBI:9434
CHEMBL1017
CID65999
CPD000466326
D00627
DB00966
|
Glaxo Wellcome brand of telmisartan
GlaxoSmithKline brand of telmisartan
HMS1922P07
HMS2051P16
HMS2090P17
HMS2093M22
HSDB 7590
I06-0281
KBio3_001958
KBioGR_001842
Kinzal
Kinzalmono
L001035
LS-44263
Micardis
Micardis (TN)
Micardis HCT
Micardis, Targit, Temax, BIBR277, Telmisartan
MLS000759432
MLS001076687
MolPort-003-666-621
NCGC00095150-01
NCGC00095150-02
NCGC00095150-03
Pritor
S1738_Selleck
SAM001246602
SMR000466326
SPBio_002131
SPECTRUM1505261
Spectrum2_001976
Spectrum3_001089
Spectrum4_001261
Spectrum5_001053
STK624049
telmisartan
Telmisartan
Telmisartan (JAN/USAN/INN)
Telmisartan [USAN:INN]
TL8000991
UNII-U5SYW473RQ
YM-086
|
|
| 10 |
|
Felodipine |
Approved, Investigational |
Phase 4,Phase 3,Not Applicable |
|
72509-76-3 |
3333
|
|
Synonyms:
(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate
(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid
(+/-) ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate
1a Brand OF felodipine
1A Brand of Felodipine
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-4-(2,3-dichlorophenyl)-2,6-dimethyl-, ethyl methyl ester
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-4-(2,3-dichlorophenyl)-2,6-dimethyl-,ethyl methyl ester
3,5-Pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, ethyl methyl ester
3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate
3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylic acid
3-ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinecarboxylic acid ethyl methyl ester
4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate ethyl methyl ester
4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester
4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester
4-(2,3-dichloro-phenyl)-2,6-dimethyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid 3-ethyl ester 5-methyl ester
5-O-ethyl 3-O-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
72509-76-3
86189-69-7
AbZ brand OF felodipine
AbZ Brand of Felodipine
AC1L1FP2
AC1Q32PZ
AC-2124
AE-641/11429675
Agon
AGON SR
Aliud brand OF felodipine
Aliud Brand of Felodipine
Alphapharm brand OF felodipine
Alphapharm Brand of Felodipine
Alpharma brand OF felodipine
Alpharma Brand of Felodipine
Astra brand OF felodipine
Astra Brand of Felodipine
AstraZeneca brand OF felodipine
AstraZeneca Brand of Felodipine
Aventis brand OF felodipine
Aventis Brand of Felodipine
Azupharma brand OF felodipine
Azupharma Brand of Felodipine
BC Brand of Felodipine
BC Brand OF felodipine
betapharm Brand of Felodipine
Betapharm brand OF felodipine
BIDD:GT0733
BPBio1_000678
BRD-A30815329-001-03-0
BRN 4331472
BSPBio_000616
C18H19Cl2NO4
CGH-869
CHEBI:127617
CHEBI:585948
CHEMBL1480
CHEMBL22571
CID3333
CPD001496951
ct Arzneimittel Brand of Felodipine
CT Arzneimittel brand OF felodipine
ct-Arzneimittel Brand of Felodipine
CT-Arzneimittel brand OF felodipine
D00319
D015736
DB01023
dl-Felodipine
DL-Felodipine
ethyl methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
EU-0100508
F 9677
F9677_SIGMA
felo Biochemie
Felo Biochemie
felo Puren
Felo Puren
Felobeta
Felocor
Feloday
Felodipin 1a pharma
Felodipin 1A Pharma
Felodipin abz
Felodipin AbZ
Felodipin al
Felodipin AL
Felodipin azu
Felodipin AZU
Felodipin dura
Felodipin heumann
Felodipin Heumann
Felodipin ratiopharm
Felodipin stada
Felodipin Stada
felodipin von ct
|
Felodipin von CT
Felodipina
Felodipina [INN-Spanish]
felodipine
Felodipine
Felodipine (JAN/USP/INN)
Felodipine [USAN:BAN:INN]
Felodipine [USAN:INN:BAN]
Felodipin-ratiopharm
Felodipinum
Felodipinum [INN-Latin]
Felodur
Felodur ER
Felogamma
Felogard
felo-Puren
Felo-Puren
Fensel
Flodil
H 154 82
H 154/82
H 15482
H 154-82
H-154/82
Heumann brand OF felodipine
Heumann Brand of Felodipine
Heumann, felodipin
Heumann, Felodipin
Hexal brand OF felodipine
Hexal Brand of Felodipine
HMS1569O18
HMS2089J05
Hoechst brand OF felodipine
Hoechst Brand of Felodipine
Hydac
I14-9560
Lexxel
Logimax
Lopac0_000508
LS-131202
Merck dura brand OF felodipine
Merck dura Brand of Felodipine
MLS000069629
MLS001077361
MLS001333735
MLS002153409
MLS002153832
Modip
MolPort-002-801-136
Munobal
Munobal Retard
NCGC00015455-03
NCGC00015455-08
NCGC00093906-01
NCGC00093906-02
Penedil
Perfudal
Pharmaceutica astra brand OF felodipine
Pharmaceutica Astra Brand of Felodipine
Pharmacia spain brand OF felodipine
Pharmacia Spain Brand of Felodipine
Plandil
Plendil
Plendil (TN)
Plendil Depottab
Plendil ER
Plendil Retard
Plendil, Renedil, Feloday, Felodipine
Preslow
Prestwick_797
Prestwick0_000478
Prestwick1_000478
Prestwick2_000478
Prestwick3_000478
Prevex
Promed brand OF felodipine
Promed Brand of Felodipine
ratiopharm Brand of Felodipine
Ratiopharm brand OF felodipine
Renedil
S1885_Selleck
SAM002589971
SMR000058204
SPBio_002555
Splendil
Stadapharm brand OF felodipine
Stadapharm Brand of Felodipine
TheraPharm brand OF felodipine
TheraPharm Brand of Felodipine
UNII-OL961R6O2C
Worwag Brand of Felodipine
Wörwag brand OF felodipine
|
|
| 11 |
|
Irbesartan |
Approved, Investigational |
Phase 4,Phase 3,Phase 2,Not Applicable |
|
138402-11-6 |
3749
|
|
Synonyms:
138402-11-6
2-Butyl-3-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-1,3-diazaspiro(4.4)non-1-en-4-one
2-butyl-3-[ p -( o -1 H -tetrazol-5-ylphenyl)benzyl]-1,3-diazaspiro[4,4]non-1-en-4-one
2-butyl-3-[2'-(1h-tetrazol-5-yl)biphenyl-4-ylmethyl]1,3-diaza-spiro[
2-butyl-3-[2'-(1h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-1,3-diaza-spiro[
2-Butyl-3-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]1,3-diaza-spiro[4.4]non-1-en-4-one
2-butyl-3-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]-1,3-diazaspiro[4.4]non-1-en-4-one
2-butyl-3-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one
2-butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one
2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one
2-n-butyl-3-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1,3-diazaspiro(4,4)non-1-en-4-one
2-N-Butyl-3-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1,3-diazaspiro(4,4)non-1-en-4-one
8-butyl-7-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-7,9-diazaspiro[4.4]non-8-en-6-one
AC1L1GMK
AC-537
Aprovel
Avalide
Avapro
Avapro (TN)
BIDD:GT0347
Bio-0053
BMS 186295
BMS Brand of Irbesartan
BMS-186295
BMS-186295, SR-47436, Aprovel, Karvea, Irbesartan
BRD-K60038276-001-02-5
Bristol Myers Brand of Irbesartan
BSPBio_002687
C07469
C081309
C25H28N6O
CHEBI:5959
CHEMBL1513
CID3749
CPD000466306
D00523
DB01029
HMS1922J05
HMS2051L08
HMS2093E16
I06-0690
|
Irbesarran
irbesartan
Irbesartan
Irbesartan (JAN/USAN/INN)
Irbesartan [Usan:Inn]
Irbesartan [USAN:INN]
Irbetan
Jsp002315
Karvea
KBio2_002231
KBio2_004799
KBio2_007367
KBio3_001907
KBioGR_001603
KBioSS_002231
L000319
Lrbesartan
LS-60064
MLS000759408
MLS001424099
MolPort-003-666-550
NCGC00095122-01
NCGC00095122-02
NCGC00095122-03
S1507_Selleck
SAM001246548
Sanofi Winthrop Brand of Irbesartan
SMR000466306
SPBio_001889
Spectrum_001751
SPECTRUM1504259
Spectrum2_001675
Spectrum3_000994
Spectrum4_001122
Spectrum5_001288
SR 47436
SR-47436
STK645362
TL8000875
UNII-J0E2756Z7N
|
|
| 12 |
|
Metoprolol |
Approved, Investigational |
Phase 4,Phase 3,Phase 2,Not Applicable |
|
37350-58-6, 51384-51-1 |
4171
|
|
Synonyms:
(+/-)-metoprolol
(RS)-Metoprolol
1-(Isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol
1-(Isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-2-propanol
1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol
1-(isopropylamino)-3-[4-(2-Methoxyethyl)phenoxy]propan-2-ol
1-[(1-methylethyl)amino]-3-({4-[2-(methyloxy)ethyl]phenyl}oxy)propan-2-ol
1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol
1-[4-(2-methoxyethyl)phenoxy]-3-propan-2-ylamino-propan-2-ol
3-[4-(2-methoxyethyl)phenoxy]-1-(propan-2-ylamino)propan-2-ol
37350-58-6
51384-51-1
54163-88-1
AB00053499
AC-19022
AC1L1HKM
AstraZeneca Brand of Metaoprolol Tartrate
AstraZeneca Brand of Seloken
Beatrolol
Beloc
Beloc duriles
Beloc Duriles
Beloc-duriles
BelocDuriles
Beloc-Duriles
Betaloc
Betaloc astra
Betaloc Astra
Betaloc-astra
BetalocAstra
Betaloc-Astra
Betalok
BRD-A03623303-045-02-0
C07202
CCRIS 4198
CGP 2175
CGP2175
CGP-2175
CHEBI:6904
CHEMBL13
CID4171
CR-XL, Metoprolol
D008790
D02358
DB00264
dl-Metoprolol
DL-metoprolol
DL-Metoprolol
Dutoprol
EINECS 253-483-7
EINECS 257-166-4
H 93 26
|
H 9326
H 93-26
HMS2090B15
HSDB 6531
I01-7125
I06-0125
Jsp006606
L000669
Leiras Brand of Metoprolol Succinate or Metoprolol Tartrate
Lopresor
Lopresoretic
LOPRESSIDONE
Lopressor
Lopressor HCT
LS-122450
Meijoprolol
Metohexal
metoprolol
Metoprolol (USAN/INN)
Metoprolol [USAN:INN:BAN]
Metoprolol CR XL
Metoprolol CR-XL
Metoprolol succinate
Metoprolol tartrate
Metoprolol Tartrate
Metoprololum
Metoprololum [INN-Latin]
Metroprolol
MolPort-005-938-039
NCGC00021148-02
NCGC00021148-03
NCGC00021148-04
Novartis Brand of Metprolol Tartrate
Preblok
Prelis
Presolol
Seloken
Seloken AstraZeneca Brand
Selopral
Selo-Zok
Seroken
Spesicor
Spesikor
Succinate, metoprolol
Tartrate, metoprolol
Tartrate, Metoprolol
Toprol
Toprol XL
ToprolXL
Toprol-XL
TOPROL-XL
UNII-GEB06NHM23
|
|
| 13 |
|
Enalapril |
Approved, Vet_approved |
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
75847-73-3 |
5362032
40466924
|
|
Synonyms:
(2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid
(S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline
(S)-1-{(S)-2-[1-((S)-ethoxycarbonyl)-3-phenyl-propylamino]-propionyl}-pyrrolidine-2-carboxylate
(S)-1-{(S)-2-[1-((S)-ethoxycarbonyl)-3-phenyl-propylamino]-propionyl}-pyrrolidine-2-carboxylic acid
1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1'-ethyl ester
75847-73-3
AC1NTUS5
Analapril
BIDD:GT0751
Bonuten
BPBio1_000340
BSPBio_000308
BSPBio_003035
C06977
CAS-76095-16-4
CHEBI:116847
CHEBI:4784
CHEMBL578
CID5388962
D07892
DivK1c_000408
enalapril
Enalapril
Enalapril (INN)
Enalapril (TN)
Enalapril Bp
Enalapril maleate
Enalapril Maleate
Enalapril Richet
Enalaprila
Enalaprila [INN-Spanish]
Enalaprilat
Enalaprilum
Enalaprilum [INN-Latin]
|
Gadopril
HMS2090E08
IDI1_000408
KBio1_000408
KBio2_001787
KBio2_004355
KBio2_006923
KBio3_002535
KBioGR_000355
KBioSS_001787
Kinfil
LS-190651
Maleate, enalapril
MolPort-002-885-877
N-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl-L-proline
N-{(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}-L-alanyl-L-proline
NCGC00016932-01
NCGC00021569-04
NCGC00021569-05
NCGC00021569-06
NINDS_000408
Prestwick3_000314
Renitec
Renitek
SPBio_001349
Spectrum_001307
Spectrum2_001455
Spectrum3_001478
Spectrum4_000008
Spectrum5_001107
Vaseretic
Vasotec
Vasotec IV
|
|
| 14 |
|
Enalaprilat |
Approved |
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
76420-72-9 |
6917719
|
|
Synonyms:
(2S)-1-[(2S)-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid
(2S)-1-[(2S)-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid dihydrate
1-((2S)-2-{[(1S)-1-CARBOXY-3-PHENYLPROPYL]AMINO}PROPANOYL)-L-PROLINE
1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline dihydrate
76420-72-9
AC1NUWEA
AC1OCEK7
Anhydrous enalaprilat citrate
Anhydrous, enalaprilat
BIDD:GT0752
Biovail brand OF enalaprilat anhydrous
Boehringer ingelheim brand OF enalaprilat anhydrous
C11720
C18H24N2O5.2H2O
CHEBI:116759
CHEBI:42302
CHEBI:4786
CHEBI:59877
CHEMBL1200697
CHEMBL577
CID5462501
CID6917719
CPD000466359
D03769
Dihydrate, enalaprilat
EAL
Enalapril acid
Enalapril diacid
Enalapril teva
Enalaprilat
Enalaprilat (USP)
Enalaprilat anhydrous
Enalaprilat citrate, anhydrous
|
Enalaprilat dihydrate
ENALAPRILAT INHIBITOR
Enalaprilat, (R)-isomer, anhydrous
Enalaprilate
Enalaprilatum
Enalaprilic acid
Enalapril-teva
EnalaprilTEVA
enalprilat hydrate
Enalprilate hydrate
HMS2051H16
HMS2089P04
LS-118903
LS-187219
Merck frosst brand OF enalaprilat anhydrous
MK-422
MLS000759476
MLS001424138
MolPort-005-943-792
MSD Brand OF enalaprilat
N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl-L-proline
N-[(1S)-1-Carboxy-3-phenylpropyl]-L-alanyl-L-proline
N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl-L-proline--water (1/2)
NCGC00164593-01
Pres IV
S1657_Selleck
SAM001246684
SBB065733
SMR000466359
Teva brand OF enalaprilat
Vasotec
Vasotec I.V.
Xanef
|
|
| 15 |
|
Hydrochlorothiazide |
Approved, Vet_approved |
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
58-93-5 |
3639
|
|
Synonyms:
125727-50-6
3,4-Dihydro-6-chloro-7-sulfamyl-1,2, 4-benzothi
3,4-Dihydrochlorothiazide
58-93-5
6-Chloro-7-sulfamoyl-3, 4-dihy
8049-49-8
AB00052012
AC-11072
AC1L1GDT
AC1Q55FM
Acesistem
Acuilix
Acuretic
adiazine-1,1-dioxide
AF-614/30832002
AKOS000121373
Aldactazide
Aldactazide 25/25
Aldazida
Aldectazide 50/50
Aldoril
Ambap58-93-5
Apo-Hydro
Apresazide
Aquarills
Aquarius
Aquazide H
Aquazide-H
ARONIS24316
BAS 00371709
BIDD:GT0153
Bio-0714
BPBio1_000019
BRD-K13078532-001-05-2
Bremil
Briazide
BRN 0625101
BSPBio_000017
BSPBio_002132
C7H8ClN3O4S2
Caplaril
Capozide
Carozide
CAS-58-93-5
Catiazida
CCRIS 2082
CHEMBL435
Chlorizide
Chlorosulthiadil
Chlorothiazide
Chlorsulfonamidodihydrobenzothiadiazine dioxide
Chlorzide
Chlothia
CID3639
Cidrex
Clorana
component of Aldactazide
component of Aldoril
Component of Butizide Prestabs
component of Caplaril
component of Cyclex
component of Dyazide
component of Esimil
Concor Plus
Condiuren
CPD000035778
D00340
D006852
DB00999
Diaqua
Dichlorosal
Dichlorotride
Dichlothiazide
Dichlotiazid
Dichlotride
diclot ride
Diclotride
Dicyclotride
Didral
Dihydran
Dihydrochlorothiazid
Dihydrochlorothiazide
Dihydrochlorothiazidum
Dihydrochlorurit
Dihydrochlorurite
Dihydroxychlorothiazidum
Direma
Disalunil
Disothiazid
Diu 25 Vigt
Diu-melusin
Diu-Melusin
Diuril
Diurogen
DivK1c_000289
Dixidrasi
Drenol
dro-2H-1,2,4-benzothiadiazine 1,1-dioxide
Dyazide
EINECS 200-403-3
Esidrex
Esidrix
Esidrix (TN)
Esimil
Esoidrina
EU-0100614
Fluvin
FT-0082750
H 4759
H1274
H2910_SIAL
H4759_SIAL
HCT
HCT-Isis
HCTZ
HCZ
Hidril
Hidrochlortiazid
Hidroclorotiazida
Hidroclorotiazida [INN-Spanish]
Hidro-Niagrin
Hidroronol
Hidrosaluretil
Hidrotiazida
HMS1568A19
HMS1920D19
HMS2091L05
HMS500O11
HMS553N04
HSDB 3096
Hyclosid
Hydrex-semi
Hydril
Hydro Par
hydro-Aquil
Hydro-Aquil
Hydro-chlor
Hydrochlorat
hydrochloro Thiazide
Hydrochlorot
Hydrochlorothiazid
hydrochlorothiazide
Hydrochlorothiazide (JP15/USP/INN)
Hydrochlorothiazide [INN:BAN:JAN]
|
Hydrochlorothiazide intensol
Hydrochlorothiazide Intensol
Hydrochlorothiazidum
Hydrochlorothiazidum [INN-Latin]
Hydrochlorthiazide
Hydrochlorthiazidum
Hydrocot
hydro-D
Hydro-D
Hydrodiuretic
hydro-Diuril
Hydrodiuril
Hydro-Diuril
HydroDIURIL
Hydropres
Hydrosaluric
Hydro-Saluric
Hydro-T
Hydrothide
Hydrozide
Hydrozide Injection, Veterinary
Hypothiazid
Hypothiazide
Hytrid
Hyzaar
I09-0531
IDI1_000289
Idroclorotiazide
Idroclorotiazide [DCIT]
Idrotiazide
Inderide
Inderide 80/25
Indroclor
Ivaugan
Jen-diril
Jen-Diril
KBio1_000289
KBio2_001357
KBio2_003925
KBio2_006493
KBio3_001352
KBioGR_000351
KBioSS_001357
Lopac0_000614
Lopac-H-4759
Lopressor HCT
Lotensin Hct
Lotensin HCT
LS-243
Manuril
Maschitt
Maxzide
Maybridge Compound 10
Maybridge1_004336
Mazide 25 mg
Medozide
Megadiuril
Microzide
Microzide (TN)
Mictrin
Mikorten
MLS000069619
Modurcen
Moduretic
MolPort-000-144-465
Natrinax
NCGC00015508-01
NCGC00015508-02
NCGC00015508-03
NCGC00015508-07
NCGC00015508-12
NCGC00021906-03
NCGC00021906-04
NCGC00021906-05
NCGC00021906-06
NCGC00021906-07
NCGC00021906-08
NCI60_004317
NCI-C55925
Nefrix
Nefrol
neo-Codema
Neo-codema
Neo-Codema
Neoflumen
Neo-Flumen
Neo-Minzil
Newtolide
NINDS_000289
Novodiurex
NSC 53477
NSC53477
Oprea1_357174
Oretic
Pantemon
Panurin
panurin dichloride
Prestwick_263
Prestwick0_000009
Prestwick1_000009
Prestwick2_000009
Prestwick3_000009
Prinzide
Raunova Plus
ro-Hydrazide
Ro-hydrazide
Ro-Hydrazide
Roxane
S1708_Selleck
Saldiuril
SAM002554901
Sectrazide
Selozide
Ser-ap-es
Servithiazid
SMR000035778
SPBio_001259
SPBio_001938
Spectrum_000877
SPECTRUM1500335
Spectrum2_001040
Spectrum3_000456
Spectrum4_000006
Spectrum5_000824
Spironazide
STK315354
Su 5879
Tandiur
Thiaretic
Thiuretic
Thlaretic
Timolide
Unazid
UNII-0J48LPH2TH
Unipres
Urodiazin
Urozide
Vaseretic
Vetidrex
WLN: T66 BSWM EM DHJ HG ISZW
Ziac
Zide
ZINC00896569
|
|
| 16 |
|
Losartan |
Approved |
Phase 4,Phase 3,Phase 2,Phase 1 |
|
114798-26-4 |
3961
|
|
Synonyms:
(2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazol-5-yl)methanol
(2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol
(2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol
[2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol
114798-26-4
124750-99-8 (mono-potassium salt)
1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- (9CI)
2-Butyl-4-chloro-1-((2'-(1H-etrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol
2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl-1H-imidazole-5-methanol
2-butyl-4-chloro-1-[p-(o-1H-tetrazol-5ylphenyl)benzyl]imidazole-5-methanol
2-n-butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole
2-N-Butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole
2-n-butyl-4-chloro-5-hydroxymethyl-1-[[2'-(1H-tetrazol-5-yl)-biphenyl-4-yl]methyl]imidazole
AC1L1H3Q
BIDD:GT0286
BRD-K76205745-001-02-5
BSPBio_002695
C07072
C22H23ClN6O
CHEBI:6541
CHEMBL191
CID3961
CL23623
Cozaar
D08146
DB00678
DuP 753
DuP 89
DUP 89
DuP-753
HMS1922J13
HMS2093E22
Hyzaar
I14-9710
Jsp001094
KBio2_002193
KBio2_004761
|
KBio2_007329
KBio3_001915
KBioGR_001611
KBioSS_002193
L000351
Lacidipine
Lortaan
losartan
Losartan
Losartan (INN)
Losartan [INN:BAN]
Losartan monopotassium salt
losartan potassium
Losartan potassium
LOSARTAN POTASSIUM
Losartic
Losartic (TN)
LS-78746
MK954
MK-954
MolPort-003-666-553
Monopotassium salt, losartan
NCGC00095125-01
NCGC00095125-02
NCGC00095125-03
Oprea1_644635
Potassium, losartan
Salt, losartan monopotassium
SPBio_001893
Spectrum_001713
SPECTRUM1504268
Spectrum2_001677
Spectrum3_000998
Spectrum4_001126
Spectrum5_001466
UNII-JMS50MPO89
|
|
| 17 |
|
Valsartan |
Approved, Investigational |
Phase 4,Phase 3,Phase 2 |
|
137862-53-4 |
60846
|
|
Synonyms:
(2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid
(s)-2-(n-((2'-(1h-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanoic acid
(S)-N-valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine
(S)-N-Valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine
|Tareg
137862-53-4
AC1L1U1M
AC1Q5QIK
AC-4543
Ambap137862-53-4
Aventis brand of valsartan
BIDD:GT0345
Bio-0796
BRD-K45158365-001-02-3
BSPBio_003501
C081489
C24H29N5O3
CEPA brand of valsartan
CGP 48933
CGP-48933
CHEBI:9927
CHEMBL1069
CID60846
CPD000466318
D00400
DB00177
Diovan
Diovan (TN)
Diovan, Valsartan
Esteve brand of valsartan
HMS1922L21
HMS2051L12
HMS2093K22
HSDB 7519
Kalpress
KBio2_002287
KBio2_004855
KBio2_007423
KBio3_003006
KBioGR_001078
KBioSS_002289
|
Lacer brand of valsartan
LS-161334
L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- (9CI)
Miten
MLS000759423
MLS001424088
MolPort-002-507-854
MolPort-003-666-608
N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine
N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine
N-(P-(O-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine
Nisis
Nisis||
Novartis brand of valsartan
N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-L-valine
N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine
N-Pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine
N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine
N-Valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine
Provas
S1894_Selleck
SAM001246581
Sanol brand of valsartan
Schwarz brand of valsartan
SMR000466318
SPBio_001260
Spectrum_001796
SPECTRUM1505209
Spectrum2_001120
Spectrum3_001831
Spectrum4_000749
Spectrum5_001582
Tareg
TL8000869
UNII-80M03YXJ7I
Vals
Valsarran
valsartan
Valsartan (JAN/USAN/INN)
Valsartan [USAN:INN]
walsartan
|
|
| 18 |
|
Lisinopril |
Approved, Investigational |
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
83915-83-7, 76547-98-3 |
5362119
|
|
Synonyms:
(2S)-1-[(2S)-6-amino-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]hexanoyl]pyrrolidine-2-carboxylic acid
(S)-1-(N(2)-(1-carboxy-3-phenylpropyl)-L-lysyl)-L-proline
(S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline
(S)-1-(N(sup 2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline
(S)-1-(N2-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline
[N2-[(S)-1-CARBOXY-3-phenylpropyl]-L-lysyl-L-proline
[N2-[(S)-1-CARBOXY-3-PHENYLPROPYL]-L-LYSYL-L-PROLINE
1-(N2-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline
1-[Nalpha-[(S)-1-Carboxy-3-phenylpropyl]-L-lysyl]-L-proline
76547-98-3
77726-95-5
83915-83-7 (Parent)
AC1NSFPF
Acerbon
Acercomp
Alapril
BB_NC-1454
BIDD:GT0755
BPBio1_000290
BRD-K67966701-335-03-5
BRN 4276619
BSPBio_000262
C21H31N3O5
Carace
CCRIS 3568
CHEBI:43755
CHEMBL1237
CID5362119
Cipral
Cipril
Coric
D08131
DB00722
DivK1c_001037
Doneka
EINECS 278-488-1
HMS1921B14
HMS2090O14
HMS2092L21
HMS503O15
I06-1895
ICI-209K
IDI1_001037
Inhibril
Inopril
KBio1_001037
KBio2_000977
KBio2_003545
KBio2_006113
KBio3_002002
KBioGR_001599
KBioSS_000977
L0220
Linopril
Linvas
Lipril
Lisinal
lisinopril
Lisinopril
|
Lisinopril (anhydrous)
Lisinopril (INN)
Lisinopril anhydrous
Lisinopril Dihydrate
Lisinopril maleate (1:1)
Lisinopril sulfate (1:2)
Lisinoprilum
Lisinoprilum [Latin]
Lisipril
Lisoril
Lispril
Longes
Loril
LPR
LS-118899
Lysinopril
MK 521
MK 522
MK-521
MLS001306436
MLS001306481
MolPort-002-507-428
N-(1(S)-Carboxy-3-phenylpropyl)-L-lysyl-L-proline
N(2)-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline
N2-((S)-1-Carboxy-3-phenylpropyl)-L-lysyl-L-proline
N2-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline
NCGC00179623-01
NINDS_001037
Noperten
Novatec
Presiten
Prestwick0_000301
Prestwick1_000301
Prestwick2_000301
Prestwick3_000301
Prinil
Prinivil
Prinzide
Renacor
Sinopril
Sinopryl
SMR000544473
SPBio_001351
SPBio_002481
Spectrum_000497
SPECTRUM1501217
Spectrum2_001456
Spectrum3_000941
Spectrum4_001040
Spectrum5_000995
Tensopril
Tensyn
Tersif
TL8005499
Vivatec
Zestoretic
Zestril
Zestril (TN)
|
|
| 19 |
|
Nitric Oxide |
Approved |
Phase 4,Phase 2,Phase 1,Not Applicable |
|
10102-43-9 |
145068
160954
|
|
Synonyms:
(.)NO
(no)(.)
(NO)(.)
[no]
[NO]
10102-43-9
14332-28-6
295566_ALDRICH
51005-20-0
51005-21-1
53851-19-7
90452-29-2
AC1L1ADQ
AC1L3QHF
AC1Q6QZ0
AR-1K7463
Bioxyde d'azote
Bioxyde d'azote [French]
C00533
CCRIS 4319
CHEMBL1200689
CHEMBL1234765
CID145068
CID945
D00074
D009569
DB00435
EDRF
EINECS 233-271-0
Endogenous nitrate vasodilator
Endogenous Nitrate Vasodilator
Endothelium-derived nitric oxide
Endothelium-Derived Nitric Oxide
endothelium-derived relaxing factor
Endothelium-derived relaxing factor
HNO
HSDB 1246
INOmax
INOmax (TN)
LS-192158
LS-7547
MolPort-003-929-452
Mononitrogen monoxide
Monoxide, mononitrogen
Monoxide, Mononitrogen
Monoxide, nitrogen
Monoxide, Nitrogen
monoxido de nitrogeno
monoxido De nitrogeno
Monoxido de nitrogeno
monoxyde d'azote
Monoxyde d'azote
Nitrate vasodilator, endogenous
Nitrate Vasodilator, Endogenous
nitric oxide
|
Nitric oxide
Nitric oxide (JAN)
Nitric oxide 10% by volume or more
Nitric oxide trimer
Nitric oxide, compressed [UN1660] [Poison gas]
Nitric oxide, compressed [UN1660] [Poison gas]
Nitric oxide, endothelium derived
Nitric Oxide, Endothelium Derived
Nitric oxide, endothelium-derived
Nitric Oxide, Endothelium-Derived
NITRIC-OXIDE
nitrogen monooxide
Nitrogen monooxide
nitrogen monoxide
Nitrogen monoxide
Nitrogen oxide
Nitrogen oxide (NO)
Nitrogen protoxide
nitrosyl
Nitrosyl
Nitrosyl hydride
Nitrosyl hydride ((NO)H)
Nitrosyl radical
Nitroxide radical
Nitroxyl
NO
no(.)
NO(.)
OHM 11771
Oxide, nitric
Oxide, Nitric
oxido de nitrogeno(II)
oxido De nitrogeno(II)
Oxido de nitrogeno(ii)
oxido nitrico
oxido Nitrico
Oxido nitrico
oxidonitrogen(.)
oxoazanyl
oxyde azotique
Oxyde azotique
Oxyde nitrique
Oxyde nitrique [French]
RCRA waste no. P076
Stickmonoxyd
Stickmonoxyd [German]
Stickstoff(ii)-oxid
Stickstoff(II)-oxid
Stickstoffmonoxid
UN 1660
UN1660
UNII-31C4KY9ESH
Vasodilator, endogenous nitrate
Vasodilator, Endogenous Nitrate
|
|
| 20 |
|
Metformin |
Approved |
Phase 4,Not Applicable |
|
657-24-9 |
14219
4091
|
|
Synonyms:
1,1-Dimethyl biguanide
1,1-Dimethylbiguanide
3-(diaminomethylidene)-1,1-dimethylguanidine
657-24-9
AC1L1HE4
AKOS000121065
Apo-Metformin
BIDD:GT0697
BPBio1_000009
BRD-K79602928-003-04-1
BSPBio_000007
BSPBio_002314
C07151
C4H11N5
CAS-1115-70-4
CCRIS 9321
CHEBI:6801
CHEMBL1431
CID4091
cMAP_000016
D04966
DB00331
Diabetosan
Diabex
Dimethylbiguanid
Dimethylbiguanide
Dimethylbiguanidine
Dimethyldiguanide
Dimethylguanylguanidine
DMGG
EINECS 211-517-8
Fluamine
Flumamine
Fortamet
Gen-Metformin
Glifage
Gliguanid
Glucophage
Glucophage XR
Glumetza
Glycon
Haurymelin
HMS2089D19
HSCI1_000295
Islotin
KBio2_002310
KBio2_004878
KBio2_007446
KBio3_002790
KBioGR_002310
|
KBioSS_002312
LA-6023
LS-43899
Melbin
metformin
Metformin
Metformin (USAN/INN)
Metformin [USAN:INN:BAN]
Metformin HCL
metformin hydrochloride
Metformina
Metformina [DCIT]
Metformina [Spanish]
Metformine
Metformine [INN-French]
Metforminum
Metforminum [INN-Latin]
Metiguanide
MolPort-002-929-560
MolPort-004-288-389
MolPort-005-767-418
Mylan-Metformin
N,N-Dimethylbiguanide
N,N-Dimethyldiguanide
N,N-dimethylimidodicarbonimidic diamide
N1,N1-Dimethylbiguanide
NCGC00016564-01
NCGC00016564-02
NCGC00016564-03
NNDG
Novo-Metformin
Nu-Metformin
PMS-Metformin
Prestwick0_000004
Prestwick1_000004
Prestwick2_000004
Prestwick3_000004
Ran-Metformin
Ratio-Metformin
Riomet
S2483_Selleck
Sandoz Metformin
Siofor
SPBio_001928
STK011633
T5895664
Teva-Metformin
UNII-9100L32L2N
ZINC12859773
|
|
| 21 |
|
Olmesartan |
Approved, Investigational |
Phase 4,Phase 3,Phase 2,Not Applicable |
|
144689-24-7, 144689-63-4 |
158781
130881
|
|
Synonyms:
144689-24-7
4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylic acid
4-(1-Hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylate
4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid
4-(1-Hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid
4-(2-hydroxypropan-2-yl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid
4-(hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl)methyl)-1H-imidazole-5-carboxylic acid
4-(Hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl)methyl)-1H-imidazole-5-carboxylic acid
4-(Hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylate
4-(hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid
4-(Hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid
5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid
AC1L4KLS
Benicar
Benicar HCT
C437965
CHEBI:48416
CHEMBL1516
CID158781
CPD000466337
CS-088
D05246
DE-092
|
HMS2051K12
I14-10085
L001097
LS-181800
MLS000759446
MLS001424016
MolPort-003-666-606
olmesartan
Olmesartan
Olmesartan (USAN/INN)
Olmesartan [USAN]
Olmesartan medoximil
Olmesartan medoxomil
Olmetec
omesartan
Omesartan
RNH 6270
RNH-6270
SAM001246634
SMR000466337
UNII-8W1IQP3U10
Votum
|
|
| 22 |
|
Carvedilol |
Approved, Investigational |
Phase 4,Phase 3,Phase 2,Phase 1 |
|
72956-09-3 |
2585
|
|
Synonyms:
(+-)-1-(Carbazol-4-yloxy)-3-((2-(o-methoxyphenoxy)ethyl)amino)-2-propanol
(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol
(+-)-1-Carbazol-4-yloxy)-3-((2-(o-methoxyphenoxy)ethyl)amino)-2-propanol
(+/-)-1-(Carbazol-4-yloxy)-3-[[2-(o-methoxyphenoxy)ethyl]amino]-2-propanol
1-(9H-carbazol-4-yloxy)-3-[(2-{[2-(methyloxy)phenyl]oxy}ethyl)amino]propan-2-ol
1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol
1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol
1-(9H-carbazol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol
107741-96-8
72956-09-3
AB1004830
AC-1641
AC1L1E0B
Artist
Artist (TN)
Atlana Pharma brand of carvedilol
Bio-0014
BM 14190
BM-14.190
BM-14190
BM-14-190
BRD-A10977446-001-04-8
BRD-A10977446-045-01-1
C043211
C06875
C2260
C24H26N2O4
carvedilol
Carvedilol
Carvedilol (JAN/USAN/INN)
Carvedilol [USAN:INN:BAN:JAN]
Carvedilol hydrochloride
carvedilol, (+-)-isomer
Carvedilol, (+-)-isomer
carvedilol, (R)-isomer
Carvedilol, (R)-isomer
carvedilol, (S)-isomer
Carvedilol, (S)-isomer
carvedilol, 14C-labeled
Carvedilol, 14C-labeled
Carvedilolum
Carvedilolum [Latin]
CHEBI:3441
CHEMBL723
CID2585
Coreg
Coreg (TN)
Coreg CR
Coropres
Coropress
|
CPD000449280
D00255
DB01136
Dibloc
Dilatrend
DQ 2466
DQ-2466
EG-P042
Eucardic
GlaxoSmithKline brand of carvedilol
HMS2051N03
HMS2089B09
HMS2093E12
HSDB 7044
I06-0064
I06-1477
KBio2_002145
KBio2_004713
KBio2_007281
KBio3_002323
KBioGR_001252
KBioSS_002145
Kredex
L001243
Lakeside brand of carvedilol
LS-121875
MLS000758299
MLS000759508
MLS001424092
MolPort-003-666-814
NCGC00167832-01
NCGC00167832-02
NCGC00167832-03
Querto
Roche brand of carvedilol
SAM001246736
SAM001247021
SK&F-105517
SKF 105517
SMR000449280
SPBio_001885
Spectrum_001665
Spectrum2_001673
Spectrum3_001182
Spectrum4_000636
Spectrum5_001436
STK621453
TL8005080
UNII-0K47UL67F2
|
|
| 23 |
|
Spironolactone |
Approved |
Phase 4,Phase 3,Phase 2,Not Applicable |
|
1952-01-7, 52-01-7 |
5833
|
|
Synonyms:
4-18-00-01601 (Beilstein Handbook Reference)
496916-40-6
4-Pregnen-21-oic acid-17alpha-ol-3-one-7alpha-thiol gamma-lactone 7-acetate
52-01-7
7alpha-(acetylsulfanyl)-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone
7-alpha-Acetylthio-3-oxo-17-alpha-pregn-4-ene-21,17-beta-carbolactone
AB00513806
Abbolactone
AC1L1L8Q
AC-4214
Acelat
Aldace
Aldactazide
Aldactide
Aldactone
Aldactone (TN)
Aldactone a
Aldactone A
Alderon
Aldopur
Almatol
Alphapharm brand OF spironolactone
Alphapharm Brand of Spironolactone
Alpharma brand OF spironolactone
Alpharma Brand of Spironolactone
Alter brand OF spironolactone
Alter Brand of Spironolactone
Altex
Aquareduct
Ashbourne brand OF spironolactone
Ashbourne Brand of Spironolactone
Azupharma brand OF spironolactone
Azupharma Brand of Spironolactone
betapharm Brand of Spironolactone
Betapharm brand OF spironolactone
BIDD:PXR0071
BPBio1_000194
BRD-K90027355-001-03-4
BRN 0057767
BSPBio_000176
C07310
C24H32O4S
Cardel brand OF spironolactone
Cardel Brand of Spironolactone
CHEBI:428201
CHEBI:45692
CHEBI:9241
CHEMBL1393
CID5833
CPD000471892
ct Arzneimittel Brand of Spironolactone
CT Arzneimittel brand OF spironolactone
ct-Arzneimittel Brand of Spironolactone
CT-Arzneimittel brand OF spironolactone
D00443
D013148
DB00421
Deverol
dexo Brand OF spironolactone
Dexo Brand of Spironolactone
Diatensec
Dira
Duraspiron
EINECS 200-133-6
Espironolactona
Espironolactona [INN-Spanish]
Espironolactona alter
Espironolactona Alter
Espironolactona mundogen
Espironolactona Mundogen
Euteberol
Flumach
Frumikal
Generosan brand OF spironolactone
Generosan Brand of Spironolactone
HMS1568I18
HMS2090N21
Hormosan brand OF spironolactone
Hormosan Brand of Spironolactone
HSDB 3184
I06-1970
Jenapharm brand OF spironolactone
Jenapharm Brand of Spironolactone
Jenaspiron
Lacalmin
Lacdene
Laractone
LS-118614
LT00772287
Mayoly-spindler brand OF spironolactone
Mayoly-Spindler Brand of Spironolactone
Melarcon
Merck dura brand OF spironolactone
Merck dura Brand of Spironolactone
MLS001074672
MLS001333253
MLS001333254
|
MLS002153245
MLS002207058
Mundogen brand OF spironolactone
Mundogen Brand of Spironolactone
NCGC00164397-01
NCGC00164397-02
Nefurofan
novo Spiroton
Novo Spiroton
Novopharm brand OF spironolactone
Novopharm Brand of Spironolactone
novo-Spiroton
NovoSpiroton
Novo-Spiroton
NSC 150399
NSC150399
Osyrol
Pfizer brand OF spironolactone
Pfizer Brand of Spironolactone
Pharmafrid brand OF spironolactone
Pharmafrid Brand of Spironolactone
Practon
Prestwick0_000128
Prestwick1_000128
Prestwick2_000128
Prestwick3_000128
Roche brand OF spironolactone
Roche Brand of Spironolactone
S0260
S3378_SIGMA
Sagisal
SAM002264648
SC 9420
SC9420
SC-9420
Searle brand OF spironolactone
Searle Brand of Spironolactone
Sincomen
SMR000471892
SNL
SPBio_002115
Spiractin
Spiresis
Spiretic
Spiridon
spiro L.U.T.
Spiro L.U.T.
spiro von ct
spiro Von CT
Spiro(17H-cyclopenta(a)phenauthrene-17,2'-(3'H)-furan)
Spiro[17H-cyclopenta[a]phenauthrene-17,2'-(3'H)-furan]
Spirobeta
Spiroctan
Spiroctanie
Spiroderm
Spirogamma
Spirolactone
Spirolakton
Spirolang
Spirolone
Spirone
spirono Isis
Spirono Isis
Spironocompren
spirono-Isis
Spirono-Isis
spironolactone
Spironolactone
Spironolactone (JP15/USP/INN)
Spironolactone [BAN:INN:JAN]
Spironolactone [INN:BAN:JAN]
Spironolactone A
Spironolactonum
Spironolactonum [INN-Latin]
spironolattone
Spironolattone
Spironolattone [DCIT]
Spironone
Spirospare
Spiro-Tablinen
Sprioderm
Supra-puren
Suracton
UNII-27O7W4T232
Uractone
Urusonin
Veroshpiron
Verospiron
Verospirone
Verospirone Opianin
von ct, spiro
Von CT, spiro
WLN: L E5 B666 FX OV MUTJ A1 E1 KSV1 F-& CT5VOXTJ
Worwag Brand of Spironolactone
Wörwag brand OF spironolactone
Xenalon
ZINC03861599
|
|
| 24 |
|
Benzocaine |
Approved, Investigational |
Phase 4,Phase 3 |
|
1994-09-7, 94-09-7 |
2337
|
|
Synonyms:
(P-(Ethoxycarbonyl)phenylamine
06952_FLUKA
112909_ALDRICH
112909_SIAL
1333-08-0
23239-88-5
23239-88-5 (hydrochloride)
4 Aminobenzoic Acid Ethyl Ester
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-14-00-01129 (Beilstein Handbook Reference)
4-Aminobenzoate
4-Aminobenzoate ethyl ester
4-Aminobenzoic acid
4-aminobenzoic acid ethyl ester
4-amino-benzoic acid ethyl ester
4-Aminobenzoic acid ethyl ester
4-Aminobenzoic acid, ethyl ester
4-Carbethoxyaniline
71123-91-6
94-09-7
94-09-7 (Parent)
A0271
AB00051923
AC1L1DGC
AC1Q341A
AC1Q64JE
Acetate, benzocaine
Acetate, Benzocaine
AE-562/40377256
Aethoform
Aethylium paraminobenzoicum
AI3-02081
AKOS000119763
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthesinum
Anaesthin
Anestezin
Anestezin [Russian]
Anesthesin
Anesthesine
Anesthone
AR-1H9065
Baby anbesol
Baby Anbesol
BB_SC-0019
Bensokain
Benzoak
Benzocaina
Benzocaina [INN-Spanish]
benzocaine
Benzocaine
Benzocaine (USP/INN)
Benzocaine [INN:BAN]
Benzocaine acetate
Benzocaine Acetate
Benzocaine formate
Benzocaine Formate
Benzocaine hydrobromide
Benzocaine Hydrobromide
Benzocaine hydrochloride
Benzocaine Hydrochloride
Benzocaine methanesulfonate
Benzocaine Methanesulfonate
Benzocainum
Benzocainum [INN-Latin]
Benzoic acid, 4-amino-, ethyl ester
Benzoic acid, 4-amino-, ethyl ester, hydrochloride
Benzoic acid, amino-, ethyl ester
Benzoic acid, p-amino-, ethyl ester
BPBio1_001017
BRD-K75466013-001-05-2
BRN 0638434
BSPBio_000923
BSPBio_001908
C07527
CAS-94-09-7
Caswell No. 430A
CHEBI:116735
CHEMBL278172
Chloraseptic
CID2337
D001566
D00552
DB01086
Dermoplast
Diet ayds
DivK1c_000932
E1501_SIGMA
EINECS 202-303-5
EPA Pesticide Chemical Code 097001
Ethoform
Ethoforme
Ethyl 4-aminobenzoate
Ethyl 4-aminobenzoate hydrochloride
Ethyl 4-aminobenzoic acid
Ethyl aminobenzoate
Ethyl Aminobenzoate
Ethyl aminobenzoate (JP15)
Ethyl aminobenzoate (VAN)
Ethyl aminobenzoic acid
|
Ethyl PABA
Ethyl P-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-Aminobenzoate
Ethyl P-aminobenzoate
Ethyl P-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethyl p-Aminophenylcarboxylate
Ethyl P-aminophenylcarboxylate
Ethyl P-aminophenylcarboxylic acid
ethylaminobenzoate-4
Ethylester kyseliny p-aminobenzoove
Ethylester kyseliny P-aminobenzoove
Ethylester kyseliny p-aminobenzoove [Czech]
Ethylis aminobenzoas
ETHYL-P-AMINOBENZOATE
Formate, benzocaine
Formate, Benzocaine
h-4-abz-oet
HMS1570O05
HMS1920G09
HMS2091M11
HMS502O14
HSDB 7225
Hurricaine
Hydrobromide, benzocaine
Hydrobromide, Benzocaine
Hydrochloride, benzocaine
Hydrochloride, Benzocaine
I05-0204
Identhesin
IDI1_000932
KBio1_000932
KBio2_000474
KBio2_003042
KBio2_005610
KBio3_001408
KBioGR_000658
KBioSS_000474
Keloform
LS-35847
Methanesulfonate, benzocaine
Methanesulfonate, Benzocaine
MLS001331704
MLS002153970
MolPort-000-871-526
NCGC00016352-01
NCGC00094598-01
NCGC00094598-02
nchembio.182-comp4
NINDS_000932
Norcain
Norcaine
Norcainum
NSC 122792
NSC 41531
NSC41531
NSC4688
Oprea1_750694
Oprea1_827402
Orabase-b
Ora-jel
Orthesin
Otocain
Outgro
p-(Ethoxycarbonyl)aniline
P-(Ethoxycarbonyl)aniline
P-Aminobenzoate
P-Aminobenzoic acid
p-Aminobenzoic acid ethyl ester
P-Aminobenzoic acid ethyl ester
p-Aminobenzoic acid, ethyl ester
p-Aminobenzoic ethyl ester
Parathesin
Parathesin (TN)
Parathesine
p-Carbethoxyaniline
P-Carbethoxyaniline
p-Ethoxycarboxylic aniline
p-Ethoxycarboxylic Aniline
P-Ethoxycarboxylic aniline
Prestwick_991
Prestwick0_000712
Prestwick1_000712
Prestwick2_000712
Prestwick3_000712
Slim mint gum
SMR000059025
Solarcaine
Solu H
SPBio_000134
SPBio_002844
Spectrum_000074
SPECTRUM1500139
Spectrum2_000117
Spectrum3_000314
Spectrum4_000249
Spectrum5_000860
STK043620
Topcaine
UNII-U3RSY48JW5
WLN: ZR DVO2
ZINC12358719
|
|
| 25 |
|
Chlorthalidone |
Approved |
Phase 4,Phase 3 |
|
77-36-1 |
2732
|
|
Synonyms:
(+-)-Chlorthalidone
(+-)-Hygroton
1-keto-3-(3'-Sulfamyl-4'-chlorophenyl)-3-hydroxyisoindoline
1-Keto-3-(3'-sulfamyl-4'-chlorophenyl)-3-hydroxyisoindoline
1-keto-3-(3'-Sulphamyl-4'-chlorophenyl)-3-hydroxyisoindoline
1-oxo-3-(3-Sulfamyl-4-chlorophenyl)-3-hydroxyisoindoline
1-Oxo-3-(3-sulfamyl-4-chlorophenyl)-3-hydroxyisoindoline
1-oxo-3-(3-Sulphamyl-4-chlorophenyl)-3-hydroxyisoindoline
2-chloro-5-(1-Hydroxy-3-oxo-1-isoindolinyl)benzenesulfonamide
2-Chloro-5-(1-hydroxy-3-oxo-1-isoindolinyl)benzenesulfonamide
2-chloro-5-(1-Hydroxy-3-oxo-1-isoindolinyl)benzenesulphonamide
2-Chloro-5-(1-hydroxy-3-oxo-2,3-dihydro-1H-isoindol-1-yl)benzenesulfonamide
2-chloro-5-(1-hydroxy-3-oxo-2H-isoindol-1-yl)benzenesulfonamide
2-chloro-5-(2,3-dihydro-1-hydroxy-3-oxo-1H-isoindol-1-yl)benzenesulfonamide
2-chloro-5-(2,3-dihydro-1-Hydroxy-3-oxo-1H-isoindol-1-yl)benzenesulfonamide
2-chloro-5-(2,3-dihydro-1-Hydroxy-3-oxo-1H-isoindol-1-yl)benzenesulphonamide
3-(4'-chloro-3'-Sulfamoylphenyl)-3-hydroxyphthalimidine
3-(4'-Chloro-3'-sulfamoylphenyl)-3-hydroxyphthalimidine
3-(4'-chloro-3'-Sulphamoylphenyl)-3-hydroxyphthalimidine
3-Hydroxy-3-(4-chloro-3-sulfamylphenyl)phthalimidine
3-Hydroxy-3-(4-chloro-3-sulphamylphenyl)phthalimidine
5-22-07-00602 (Beilstein Handbook Reference)
77-36-1
A3836/0162845
AB00051946
AC-11367
AC1L1ECB
AC1Q558X
BPBio1_000487
BRD-A26384407-001-05-3
BRN 0312295
BSPBio_000441
BSPBio_002017
C14H11ClN2O4S
C2775_FLUKA
C2775_SIGMA
CHEBI:3654
CHEMBL1055
Chlorothalidone
Chlorphthalidolone
Chlorphthalidone
Chlortalidone
Chlortalidone (JAN/INN)
Chlortalidonum
Chlortalidonum [INN-Latin]
Chlorthalidon
chlorthalidone
Chlorthalidone
Chlorthalidone (USP)
Chlorthalidone [USAN:INN:BAN]
CID2732
Clodronic Acid
Clortalidona
Clortalidona [INN-Spanish]
Clortalidone
Clortalidone [DCIT]
CPD000058635
D00272
D002752
DB00310
DivK1c_000731
EINECS 201-022-5
Famolin
G 33182
|
G-33182
Higroton
HMS1569G03
HMS1920M09
HMS2091E12
HMS502E13
HSDB 3035
Hydro-Long
Hygroton
Hygroton (TN)
I06-0208
IDI1_000731
Igroton
Isoren
KBio1_000731
KBio2_000626
KBio2_003194
KBio2_005762
KBio3_001237
KBioGR_001574
KBioSS_000626
LS-31408
MLS000069531
MolPort-002-736-049
Natriuran
NCGC00094616-01
NCGC00094616-02
NCGC00094616-03
NCGC00094616-04
NINDS_000731
NSC 69200
NSC69200
Oksodolin (oxodolin)
Oradil
Oxodolin
Oxodoline
Phthalamodine
Phthalamudine
Prestwick_759
Prestwick0_000351
Prestwick1_000351
Prestwick2_000351
Prestwick3_000351
Racemic chlorthalidone
Renon
Saluretin
SAM002589983
SMR000058635
SPBio_000058
SPBio_002362
Spectrum_000146
SPECTRUM1500187
Spectrum2_000099
Spectrum3_000349
Spectrum4_000957
Spectrum5_000743
ST088141
STK686335
Tenoretic
Thalitone
Thalitone (TN)
UNII-Q0MQD1073Q
Urolin
Zambesil
|
|
| 26 |
|
Eprosartan |
Approved |
Phase 4,Phase 3 |
|
133040-01-4 |
5281037
|
|
Synonyms:
(4-carboxybenzyl)imidazole-5-acrylic acid
(e)-2-Butyl-1-(P-carboxybenzyl)-a-2-thenylimidazole-5-acrylate
(e)-2-Butyl-1-(P-carboxybenzyl)-a-2-thenylimidazole-5-acrylic acid
(e)-2-Butyl-1-(P-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylate
(e)-2-Butyl-1-(P-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid
(E)-2-Butyl-1-(p-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid
(e)-2-Butyl-1-(P-carboxybenzyl)-α-2-thenylimidazole-5-acrylate
(e)-2-Butyl-1-(P-carboxybenzyl)-α-2-thenylimidazole-5-acrylic acid
(e)-3-[2-N-Butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoate
(e)-3-[2-N-Butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid
(E)-3-[2-n-butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid
(e)-Alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionate
(e)-Alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid
(E)-alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid
133040-01-4
4-({2-butyl-5-[(1E)-2-carboxy-3-(2-thienyl)prop-1-en-1-yl]-1H-imidazol-1-yl}methyl)benzoic acid
4-({2-butyl-5-[(1E)-2-carboxy-3-(thiophen-2-yl)prop-1-en-1-yl]-1H-imidazol-1-yl}methyl)benzoic acid
4-[[2-butyl-5-[(E)-3-hydroxy-3-oxo-2-(thiophen-2-ylmethyl)prop-1-enyl]imidazol-1-yl]methyl]benzoic acid
AC1NQXXN
BIDD:GT0030
Bio-0035
C07467
C23H24N2O4S
CHEBI:4814
|
CHEMBL813
CID5281037
D04040
Eprosartan
Éprosartan
Eprosartan (USAN/INN)
Eprosartan [USAN:BAN:INN]
Eprosartanum
HMS2089O10
HSDB 7521
L000248
LS-172855
MolPort-003-847-076
NCGC00164557-01
SK And F 108566
SK&F 108566
SK&F-108566
SK-108566
SKF-108566
STK618317
Teveten
TL8000785
UNII-2KH13Z0S0Y
|
|
| 27 |
|
Lercanidipine |
Approved, Investigational |
Phase 4,Phase 3,Phase 2 |
|
100427-26-7 |
65866
|
|
Synonyms:
(+-)-2-((3,3-Diphenylpropyl)methylamino)-1,1-dimethylethyl methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate
1-[(3,3-diphenylpropyl)(methyl)amino]-2-methylpropan-2-yl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
100427-26-7
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-[2-[(3,3-diphenylpropyl)methylamino]-1,1-dimethylethyl] 5-methyl ester
5-O-[1-[3,3-diphenylpropyl(methyl)amino]-2-methylpropan-2-yl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
AC-15409
AC1L244Q
AC1Q1ZXR
Biohorm brand OF lercanidipine hydrochloride
C36H41N3O6
CHEMBL250270
CID65866
D08111
DB00528
I06-0228
Lercadip
Lercanidipine
Lercanidipine (INN)
|
Lercanidipine [INN]
Lercanidipine hydrochloride
Lercanil
Lercanil (TN)
Lerdip
LS-130876
masnidipine
methyl-1,1-dimethyl-2-(N-(3,3-diphenylpropyl)-N-methylamino)ethyl-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
Methyl-1,1-dimethyl-2-(N-(3,3-diphenylpropyl)-N-methylamino)ethyl-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
MolPort-005-935-354
NCGC00167492-01
NCGC00167492-02
REC 15-2375
REC-15-2375
STK639861
UNII-V7XTJ4R0BH
Zanidip
|
|
| 28 |
|
Atenolol |
Approved |
Phase 4,Phase 3 |
|
29122-68-7 |
2249
|
|
Synonyms:
( inverted question mark)-Atenolol
(?)-Atenolol
(+-)-4-(2-Hydroxy-3-isopropylaminopropoxy)phenylacetamide
(+-)-Atenolol
(+/-)-4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide
(1)-2-(4-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide
1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol
1-P-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol
2-(4-(2-Hydroxy-3-isopropylaminopropoxy)phenyl)acetamid
2-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)acetamide
2-(p-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide
2-(P-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide
2-[4-({2-hydroxy-3-[(1-methylethyl)amino]propyl}oxy)phenyl]acetamide
2-[4-(2-Hydroxy-3-isopropylaminopropoxy)phenyl]acetamide
2-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide
2-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}acetamide
29122-68-7
4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide
4-[2 -Hydroxy-3 -(isopropylamino)-propoxy]phenylacetamide
4-[2'-Hydroxy-3'-(isopropylamino)propoxy]phenylacetamide
60966-51-0
A 7655
A7655_SIGMA
AC-11142
AC1L1D99
AC1Q1QBX
Acetamide,2-(p-(2-hydroxy-3-(isopropylamino)propoxy)phenyl)
Aircrit
AKOS005111050
Alinor
Altol
Anselol
Antipressan
apo-Atenolol
Apo-Atenolol
ARONIS23884
Atcardil
Atecard
Atehexal
Atenblock
Atendol
Atenet
Ateni
Atenil
Atenol
Atenol 1a pharma
Atenol 1A pharma
Atenol 1A Pharma
Atenol acis
Atenol Acis
Atenol al
Atenol AL
Atenol atid
Atenol Atid
Atenol cophar
Atenol Cophar
Atenol ct
Atenol CT
Atenol fecofar
Atenol Fecofar
Atenol gador
Atenol Gador
Atenol genericon
Atenol Genericon
Atenol GNR
Atenol heumann
Atenol Heumann
Atenol MSD
Atenol NM pharma
Atenol NM Pharma
Atenol nordic
Atenol Nordic
Atenol PB
Atenol quesada
Atenol Quesada
Atenol stada
Atenol Stada
Atenol tika
Atenol Tika
Atenol trom
Atenol Trom
Atenol von ct
Atenol von CT
Atenol Von CT
Atenolin
Atenol-mepha
Atenol-Mepha
atenolol
Atenolol (JP15/USP/INN)
Atenolol [USAN:INN:BAN:JAN]
Atenololum
Atenololum [INN-Latin]
Atenol-ratiopharm
Atenol-Ratiopharm
Atenol-wolff
Atenol-Wolff
Atenomel
Atereal
Aterol
BB_SC-1519
benzeneacetamide, 4-[2'-hydroxy-3
Betablok
Betacard
Betasyn
Betatop ge
Betatop Ge
Betatop GE
BIM-0050109.0001
Blocotenol
Blokium
BRD-A20239487-001-02-5
BRN 2739235
BSPBio_002915
Cardaxen
Cardiopress
CCRIS 4196
CHEBI:2904
CHEMBL24
CID2249
|
Corotenol
CPD000036768
Cuxanorm
D001262
D00235
DB00335
DivK1c_000057
Duraatenolol
duratenol
Duratenol
EINECS 249-451-7
EINECS 262-544-7
EU-0100121
Evitocor
Farnormin
felo-Bits
Felo-Bits
Hipres
HMS1569L13
HMS1921H09
HMS2090I19
HMS2092D19
HMS500C19
HSDB 6526
Hypoten
I01-3572
Ibinolo
ICI 66,082
ICI 66082
ICI66082
ICI-66082
IDI1_000057
InChI=1/C14H22N2O3/c1-10(2)16-8-12(17)9-19-13-5-3-11(4-6-13)7-14(15)18/h3-6,10,12,16-17H,7-9H2,1-2H3,(H2,15,18)
Internolol
Jenatenol
Juvental
KBio1_000057
KBio2_001844
KBio2_004412
KBio2_006980
KBio3_002415
KBioGR_000790
KBioSS_001844
L000116
Lopac0_000121
lo-Ten
Loten
Lo-ten
Lo-Ten
Lotenal
LS-28557
LS-9707
MLS000069622
MLS001066372
MLS001074163
MLS001304038
MolPort-001-792-717
Myocord
NCGC00015007-07
NCGC00015007-13
NCGC00024566-03
NCGC00024566-04
NCGC00024566-05
NCGC00024566-06
NCGC00024566-07
Neatenol
NINDS_000057
Normalol
Normiten
Noten
Oprea1_448775
Oraday
Ormidol
Panapres
Plenacor
Premorine
Prenolol
Prenormine
Prinorm
SAM002564193
Scheinpharm atenol
Scheinpharm Atenol
Seles beta
Seles Beta
Selobloc
Serten
Servitenol
SMR000036768
SPBio_001482
Spectrum_001364
SPECTRUM1501127
Spectrum2_001411
Spectrum3_001448
Spectrum4_000435
Spectrum5_001509
Stermin
STK528649
Tenidon
Teno-basan
Teno-Basan
Tenobloc
Tenoblock
Tenolol
Tenoprin
Tenoretic
Tenormin
Tenormin (TN)
Tenormine
Tenormine [French]
Tensimin
Tensotin
Tredol
Unibloc
UNII-50VV3VW0TI
Uniloc
Vascoten
Vericordin
Wesipin
Xaten
|
|
| 29 |
|
Lacidipine |
Approved, Investigational |
Phase 4,Phase 3 |
|
103890-78-4 |
|
| 30 |
|
Doxazosin |
Approved |
Phase 4,Phase 2,Phase 3 |
|
74191-85-8 |
3157
|
|
Synonyms:
[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone
1 (4-amino-6,7-Dimethoxy-2-quinazolinyl)-4-((2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl)piperazine
1-(4-amino-6,7-Dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin
1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin
1-(4-amino-6,7-Dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin
1-(4-Amino-6,7-Dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[4-(1,4-benzodioxan-2-yl)carpiperazin-1-yl)]-6,7-dimethoxyquinazoline mesylate
2-[4-(2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl)piperazin-1-yl]-6,7-bis(methyloxy)quinazolin-4-amine
2-[4-(2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine
2-{4-[(2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl]piperazin-1-yl}-6,7-dimethoxyquinazolin-4-amine
74191-85-8
77883-43-3 (mesylate)
AC-11062
AC1L1FAT
AC1Q470P
AC1Q4EXN
AKOS001681453
Alfamedin
Aliud brand OF doxazosin mesylate
Almirall brand OF doxazosin mesylate
Alpharma brand OF doxazosin mesylate
Alter brand OF doxazosin mesylate
apo Doxazosin
apo-Doxazosin
Apogepha brand OF doxazosin mesylate
Apotex brand OF doxazosin mesylate
AstraZeneca brand OF doxazosin mesylate
Azupharma brand OF doxazosin mesylate
Betapharm brand OF doxazosin mesylate
BPBio1_000963
BRD-A13188892-066-03-3
BSPBio_000875
C06970
C23H25N5O5
Cantabria brand OF doxazosin mesylate
Cardular
Cardura
Cardura XL (TN)
Cardura-1
Cardura-2
Cardura-4
Carduran
Carduran neo
CHEBI:4708
CHEMBL707
ChemDiv2_005017
Ciclum brand OF doxazosin mesylate
CID3157
Cinfa brand OF doxazosin mesylate
combino Brand OF doxazosin mesylate
CPD000097306
CT Arzneimittel brand OF doxazosin mesylate
CT-Arzneimittel brand OF doxazosin mesylate
D07874
D9815_SIGMA
DB00590
Diblocin
Doxa puren
Doxacor
Doxagamma
Doxamax
Doxa-puren
Doxatensa
DoxaUro
Doxazomerck
doxazosin
Doxazosin (INN)
Doxazosin [INN:BAN]
Doxazosin al
Doxazosin apogepha
Doxazosin azu
Doxazosin beta
Doxazosin findusfit
Doxazosin heumann
Doxazosin klast
Doxazosin mesilate
Doxazosin mesylate
Doxazosin monohydrochloride
Doxazosin ratiopharm
|
Doxazosin stada
Doxazosin von CT
Doxazosin wolff
Doxazosina
Doxazosina [Spanish]
Doxazosina alter
Doxazosina cinfa
Doxazosina combino pharm
Doxazosina geminis
Doxazosina normon
Doxazosina pharmagenus
Doxazosina ratiopharm
Doxazosina ur
Doxazosine
Doxazosine [French]
Doxazosin-ratiopharm
Doxazosinum
Doxazosinum [Latin]
Doxazosin-wolff
Esparma brand OF doxazosin mesylate
FindusFit brand OF doxazosin mesylate
Geminis brand OF doxazosin mesylate
Gen doxazosin
Gen-doxazosin
Genpharm brand OF doxazosin mesylate
Heumann brand OF doxazosin mesylate
Hexal brand OF doxazosin mesylate
HMS1383E01
HMS2090C20
I06-1346
IDI1_003732
Juta brand OF doxazosin mesylate
Jutalar
Kade brand OF doxazosin mesylate
L000738
Linden brand OF doxazosin mesylate
Lopac0_000474
LS-110228
Merck dura brand OF doxazosin mesylate
Mesylate, doxazosin
MolPort-001-684-491
Monohydrochloride, doxazosin
MTW Brand OF doxazosin mesylate
MTW Doxazosin
MTW-Doxazosin
NCGC00018158-06
NCGC00089775-02
neo, Carduran
Normon brand OF doxazosin mesylate
Normothen
novo Doxazosin
novo-Doxazosin
Novopharm brand OF doxazosin mesylate
Oprea1_259518
Pfizer brand OF doxazosin mesylate
Pharmagenus brand OF doxazosin mesylate
Prestwick0_000858
Prestwick1_000858
Prestwick2_000858
Prestwick3_000858
Progandol neo
Q Pharm brand OF doxazosin mesylate
Q-Pharm brand OF doxazosin mesylate
ratio Doxazosin
ratio-Doxazosin
Ratiopharm brand OF doxazosin mesylate
Ratiopharm, doxazosina
SAM002589981
Solvay brand OF doxazosin mesylate
SPBio_002796
Stadapharm brand OF doxazosin
TAD brand OF doxazosin mesylate
UK 33274
UK-33274
UNII-NW1291F1W8
Uriduct
Wolff brand OF doxazosin mesylate
Wörwag brand OF doxazosin mesylate
Zoxan
|
|
| 31 |
|
Nebivolol |
Approved, Investigational |
Phase 4,Phase 3,Phase 2 |
|
152520-56-4, 99200-09-6, 118457-14-0 |
71301
|
|
Synonyms:
1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)-2-[[2-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)-2-hydroxyethyl]amino]ethanol
1,1'-[Bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)]-2,2'-iminodiethanol
1,1'-Bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)-2,2'-iminodiethanol
104365-59-5
118457-14-0
2,2'-iminobis[1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)ethanol]
99200-09-6
a,Alpha'-(iminobismethylene)bis-(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol)
AC-1611
AC1L2FX8
AC1Q4OMF
alpha,alpha'-(iminobis(methylene))bis(6-fluoro-3,4-dihydro)-2H-1-benzopyran-2-methanol
alpha,Alpha'-(iminobis(methylene))bis(6-fluoro-3,4-dihydro)-2H-1-benzopyran-2-methanol
alpha,alpha'-(Iminobis(methylene))bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol)
alpha,alpha'-(iminobismethylene)bis-(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol)
alpha,Alpha'-(iminobismethylene)bis-(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol)
alpha,alpha'-(iminodimethylene)bis-(6-fluoro-2-chromanmethanol)
alpha,alpha'-(Iminodimethylene)bis(6-fluoro-2-chromanmethanol)
Bystolic
C22H25F2NO4
CHEMBL434394
CID71301
D05127
DB04861
Hydrochloride, nebivolol
I06-0378
L001284
|
Lobivon
LS-178404
MolPort-003-849-343
Narbivolol
Nebicard-5
Nebilet
Nebilong
Nebipill
Nebivolol
Nebivolol (USAN/INN)
Nebivolol [USAN:INN:BAN]
Nebivolol hydrochloride
Nebivololum
nebivololum [latin]
Nebivololum [Latin]
Nodon
Nubeta
PDSP1_000244
PDSP2_000243
PI-21858
R 67555
R65,824
R-67555
Silostar
UNII-030Y90569U
α,alpha'-(iminobismethylene)bis-(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol)
|
|
| 32 |
|
Aspirin |
Approved, Vet_approved |
Phase 4 |
|
50-78-2 |
2244
|
|
Synonyms:
11126-35-5
11126-37-7
1oxr
2-(ACETYLOXY)benzoate
2-(ACETYLOXY)benzoIC ACID
2349-94-2
26914-13-6
2-Acetoxybenzenecarboxylate
2-Acetoxybenzenecarboxylic acid
2-Acetoxybenzoate
2-Acetoxybenzoic acid
2-Carboxyphenyl acetate
50-78-2
8-hour Bayer
98201-60-6
A 5376
A.S.A
A.S.A.
A.S.A. empirin
A.S.A. Empirin
A2093_SIGMA
A3160_SIGMA
A5376_SIGMA
A6810_SIGMA
AB1003266
AC 5230
AC1L1D8U
AC1Q1LA0
Acenterine
Acesal
Acetal
Acetard
Aceticyl
Acetilsalicilico
Acetilum acidulatum
Acetisal
Acetol
Acetonyl
Acetophen
Acetosal
Acetosalic acid
Acetosalin
Acetoxybenzoic acid
Acetylin
Acetylsal
Acetylsalicylate
Acetylsalicylic acid
ACETYLSALICYLIC ACID
Acetylsalicylsaeure
Acetylsalicylsaure
Acetylsalicylsäure
Acetylsalycilic acid
Acetyonyl
Acetysal
Acetysalicylic acid
Acid, acetylsalicylic
Acide 2-(acetyloxy)benzoique
acide 2-(acétyloxy)benzoïque
Acide acetylsalicylique
acide acétylsalicylique
acido Acetilsalicilico
Acido acetilsalicilico
ácido acetilsalicílico
Acido O-acetil-benzoico
Acidum acetylsalicylicum
Acimetten
Acisal
Acylpyrin
Adiro
AI3-02956
AIN
AKOS000118884
Aloxiprimum
ASA
Asacard
Asagran
Asatard
Ascoden-30
Aspalon
Aspec
Aspergum
Aspirdrops
aspirin
Aspirin
Aspirin (JP15/USP)
Aspirin [BAN:JAN]
Aspirina 03
Aspirine
Aspir-Mox
Asprin
Aspro
Aspro Clear
Asteric
Azetylsalizylsaeure
Azetylsalizylsäure
Bay-e-4465
Bayer
Bayer Aspirin 8 Hour
Bayer Buffered
Bayer Extra Strength Aspirin For Migraine Pain
Bayer Plus
Benaspir
Bialpirina
Bialpirinia
BIDD:GT0118
Bi-prin
BRN 0779271
Bufferin
C01405
Caprin
Cardioaspirin
Cardioaspirina
CCRIS 3243
Cemirit
CHEBI:15365
CHEMBL25
CID2244
Claradin
Clariprin
cMAP_000006
Colfarit
component of Midol
component of Synirin
Contrheuma retard
Coricidin
Crystar
D00109
D001241
DB00945
Decaten
Delgesic
Dispril
DivK1c_000555
Dolean pH 8
Duramax
Easprin
Easprin (TN)
ECM
Ecolen
Ecotrin
EINECS 200-064-1
Empirin
Empirin with Codeine
|
Endosprin
Endydol
Entericin
Enterophen
Enterosarein
Enterosarine
Entrophen
EU-0100038
Extren
Globentyl
Globoid
Helicon
HMS1920E13
HMS2090G03
HMS2091K13
HMS501L17
HSDB 652
I14-7505
IDI1_000555
Idragin
Istopirin
Kapsazal
KBio1_000555
KBio2_001725
KBio2_002271
KBio2_004293
KBio2_004839
KBio2_006861
KBio2_007407
KBio3_002149
KBio3_002751
KBioGR_000398
KBioGR_002271
KBioSS_001725
KBioSS_002272
Kyselina 2-acetoxybenzoova
Kyselina acetylsalicylova
Levius
Lopac0_000038
Lopac-A-5376
LS-143
Magnecyl
Measurin
Medisyl
Micristin
MLS001055329
MLS001066332
MLS001336045
MLS001336046
MolPort-000-871-622
NCGC00015067-01
NCGC00015067-04
NCGC00015067-09
NCGC00090977-01
NCGC00090977-02
NCGC00090977-03
NCGC00090977-04
NCGC00090977-05
NCGC00090977-06
NCGC00090977-07
nchem.859-comp6
NCI60_002222
Neuronika
NINDS_000555
Novid
NSC 27223
NSC27223
NSC406186
Nu-seals
Nu-seals aspirin
O-(Acetyloxy)benzoate
O-(Acetyloxy)benzoic acid
O-accetylsalicylic acid
O-Acetoxybenzoate
o-acetoxybenzoic acid
o-Acetoxybenzoic acid
O-Acetoxybenzoic acid
O-Acetylsalicylate
O-acetylsalicylic acid
O-Acetylsalicylic acid
o-carboxyphenyl acetate
o-Carboxyphenyl acetate
O-Carboxyphenyl acetate
O-Carboxyphenyl acetic acid
Persistin
Pharmacin
Pirseal
PL-2200
Polopirin
Polopiryna
Premaspin
R16CO5Y76E [UNII]
Rheumin tabletten
Rheumintabletten
Rhodine
Rhonal
Ronal
S-211
Salacetin
Salcetogen
Saletin
Salicylate acetate
salicylic acid acetate
Salicylic acid acetate
Salicylic acid acetic acid
Salicylic acid, acetate
Salospir
SMR000059138
Solfrin
Solprin
Solprin acid
Solpyron
Solupsan
SP 189
SPBio_001838
Spectrum_001245
SPECTRUM1500130
Spectrum2_001899
Spectrum3_001295
Spectrum4_000099
Spectrum5_000740
Spira-Dine
St. Joseph
St. Joseph Aspirin for Adults
ST075414
Supac
Tasprin
Temperal
Toldex
Triaminicin
Triple-sal
UNII R16CO5Y76E
UNII=R16CO5Y76E
UNII-R16CO5Y76E
UNM-0000306102
Vanquish
WLN: QVR BOV1
Xaxa
XAXA
Yasta
Zorprin
ZORprin
|
|
| 33 |
|
Allopurinol |
Approved |
Phase 4,Phase 2 |
|
315-30-0 |
2094
|
|
Synonyms:
1,5-dihydro-4H-pyrazolo(3,4-D)Pyrimidin-4-one
1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one
1,5-dihydro-4H-pyrazolo(3,4-D)Pyrimidine-4-one
1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidine-4-one
184856-42-6
1H-pyrazolo(3,4-D)Pyrimidin-4-ol
1H-Pyrazolo(3,4-d)pyrimidin-4-ol
22767-92-6
315-30-0
39464-14-7
4-HPP
4H-pyrazolo(3,4-D)Pyrimidin-4-one
4H-Pyrazolo(3,4-d)pyrimidin-4-one
4-Hydroxy-1H-pyrazolo(3,4-d)pyrimidine
4-Hydroxy-1H-pyrazolo(3,4-D)pyrimidine
4-Hydroxy-3,4-pyrazolopyrimidine
4-hydroxypyrazolo(3,4-D)Pyrimidine
4-Hydroxypyrazolo(3,4-d)pyrimidine
4'-Hydroxypyrazolol(3,4-d)pyrimidine
4'-Hydroxypyrazolol(3,4-D)pyrimidine
4-Hydroxypyrazolopyrimidine
4-Hydroxypyrazolyl(3,4-d)pyrimidine
4-Hydroxypyrazolyl(3,4-D)pyrimidine
7HP
A 8003
A0907
A8003_SIGMA
AC-019
AC1L1CWL
AC1Q6FWV
AC1Q6GP7
Adenock
Ailural
Ailurial
AKOS000267490
AKOS000269759
AL-100
Allohexal
Allohexan
Alloprin
Allopur
Allo-Puren
Allopurin
allopurinol
Allopurinol alphapharm brand
Allopurinol amrad brand
Allopurinol aps brand
Allopurinol ashbourne brand
Allopurinol azupharma brand
Allopurinol basf brand
Allopurinol bicther brand
Allopurinol boots brand
Allopurinol clonmel brand
Allopurinol dorsch brand
Allopurinol douglas brand
Allopurinol gepepharm brand
Allopurinol hennig brand
Allopurinol hexal brand
Allopurinol horner brand
Allopurinol icn brand
Allopurinol jenapharm brand
Allopurinol merckle brand
Allopurinol merz brand
Allopurinol multipharma brand
Allopurinol nicholas brand
Allopurinol novopharm brand
Allopurinol pharmafarm brand
Allopurinol pinewood brand
Allopurinol protea brand
Allopurinol r.a.n. brand
Allopurinol rima brand
Allopurinol roche brand
Allopurinol rosen brand
Allopurinol rougier brand
Allopurinol Sodium
Allopurinol tad brand
Allopurinol thiemann brand
Allopurinol wellcome brand
Allopurinol(I)
Allopurinolum
Allopurinolum [INN-Latin]
Allorin
Allozym
Allpargin
Allural
Aloprim
Alopurinol
Alopurinol [INN-Spanish]
Aloral
Alositol
Alphapharm brand OF allopurinol
Aluline
Amrad brand OF allopurinol
Anoprolin
Anzief
Apo-Allopurinol
APS brand OF allopurinol
Apulonga
Apurin
Apurol
Ashbourne brand OF allopurinol
Atisuril
Azupharma brand OF allopurinol
B. W. 56-158
BASF brand OF allopurinol
BB_SC-5394
Bicther brand OF allopurinol
BIM-0061756.0001
Bio-0799
Bleminol
Bloxanth
Boehringer mannheim brand OF allopurinol
Boots brand OF allopurinol
BSPBio_001798
BW 56158
BW 56-158
BW-56-158
Byk gulden brand OF allopurinol
C5H4N4O
Caplenal
Capurate
CCRIS 626
Cellidrin
CHEBI:40279
CHEBI:495607
CHEMBL1467
CID2094
Clonmel brand OF allopurinol
Cosuric
CPD000059083
CPD-9024
D000493
Dabrosin
Dabroson
DB00437
DivK1c_000685
Dorsch brand OF allopurinol
Douglas brand OF allopurinol
Dura Al
EINECS 206-250-9
Embarin
|
EN000932
Epidropal
Epuric
EU-0100102
Fawns and mcallan brand OF allopurinol
Foligan
Geapur
Gepepharm brand OF allopurinol
Gichtex
glaxo Wellcome brand OF allopurinol
Gotax
Hamarin
Hennig brand OF allopurinol
Henning berlin brand OF allopurinol
Hexal brand OF allopurinol
Hexanuret
HMS1920A15
HMS2091G15
HMS502C07
Horner brand OF allopurinol
HPP
HSDB 3004
I03-0052
ICN brand OF allopurinol
IDI1_000685
Jenapharm brand OF allopurinol
Jenapurinol
Jsp005881
KBio1_000685
KBio2_000386
KBio2_002954
KBio2_005522
KBio3_001298
KBioGR_000550
KBioSS_000386
Ketanrift
Ketobun-A
Ledopur
Lopac0_000102
Lopac-A-8003
Lopurin
LS-1180
Lysuron
Merckle brand OF allopurinol
Merz brand OF allopurinol
Milurit
Milurite
Miniplanor
MLS000069453
MLS001148183
MolPort-000-141-383
MolPort-000-870-337
MolPort-004-758-159
MolPort-004-758-166
MolPort-004-758-167
MolPort-004-758-643
Monarch
Multipharma brand OF allopurinol
NCGC00015094-01
NCGC00015094-03
NCGC00015094-06
NCGC00091134-01
NCGC00091134-02
NCGC00091134-03
NCGC00094580-01
NCGC00094580-02
nchembio.92-comp3
nchembio732-comp4
NCIOpen2_001825
Nektrohan
Nicholas brand OF allopurinol
NINDS_000685
Novopharm brand OF allopurinol
Novopurol
NSC 101655
NSC 1390
NSC101655
NSC1390
NSC-1390
Pan quimica
Pan Quimica
Pharmafarm brand OF allopurinol
Pinewood brand OF allopurinol
Prestwick_511
Progout
Protea brand OF allopurinol
Pureduct
Purinol
Quimica, pan
Quimica, Pan
R.A.N. brand OF allopurinol
Reig jofre brand OF allopurinol
Remid
Rhône poulenc rorer brand OF allopurinol
Rhône-poulenc rorer brand OF allopurinol
Riball
Rima brand OF allopurinol
Rimapurinol
Roche brand OF allopurinol
Rosen brand OF allopurinol
Roucol
Rougier brand OF allopurinol
S1630_Selleck
SAM002554884
Sigapurol
SMR000059083
SPBio_000056
Spectrum_000026
SPECTRUM1500108
Spectrum2_000098
Spectrum3_000289
Spectrum4_000135
Spectrum5_000768
STK378584
STK711106
Suspendol
TAD brand OF allopurinol
Takanarumin
Thiemann brand OF allopurinol
Tipuric
UNII-63CZ7GJN5I
Urbol
Uribenz
Uricemil
Uridocid
Uriprim
Uripurinol
Uritas
Urobenyl
Urolit
Urosin
Urtias
Urtias 100
Wellcome brand OF allopurinol
Xanthomax
Xanturat
Xanturic
Zygout
Zyloprim
Zyloric
|
|
| 34 |
|
Eplerenone |
Approved |
Phase 4,Phase 3,Phase 2,Not Applicable |
|
107724-20-9 |
150310
443872
|
|
Synonyms:
107724-20-9
7alpha-methoxycarbonyl-3-oxo-9,11alpha-epoxy-17alpha-pregn-4-ene-21,17-carbolactone
9,11-Epoxy-7-(methoxycarbonyl)-3-oxo-17-pregn-4-ene-21,17-carbolactone
AC1L9FDC
AC-4213
C12512
CGP-30083
CHEBI:31547
CHEBI:726453
CHEMBL1095097
CID443872
D01115
Eplerenon
Eplerenone
|
Eplerenone (JAN/USAN/INN)
Epoxymexrenone
Inspra
Inspra (TN)
Inspra, Epoxymexrenone, CGP30083, SC-66110,Eplerenone
MolPort-003-986-216
NCGC00159559-01
NCGC00159559-02
S1707_Selleck
SC-66110
Selara
TL8000270
ZINC03985982
|
|
| 35 |
|
Hydralazine |
Approved |
Phase 4 |
|
86-54-4 |
3637
|
|
Synonyms:
(1Z)-1(2H)-Phthalazinone hydrazone
(2H)-Phthalazinone hydrazone
[2H-Phthalazin-(1Z)-Ylidene]-Hydrazine Hydrochloride
1(2H)-Phthalazinone hydrazone
1(2H)-Phthalazinone, hydrazone
1-Hydrazinophthalazine
1-Phthalazinylhydrazine
304-20-1 (mono-hydrochloride)
5-25-17-00412 (Beilstein Handbook Reference)
6-Hydralazine
86-54-4
AC1L1GDN
AC1Q4UY1
AKOS000122609
Apresolin
Apresoline
Apressin
Apressin (pharmaceutical)
Apressoline
Aprezolin
BA 5968
BRD-K82103381-003-03-7
BRN 0132615
BSPBio_002130
C 5968
C07040
C-5068
C-5968
C8H8N4
CAS-304-20-1
CCRIS 5385
CHEBI:5775
CHEMBL276832
Ciba 5968
CID3637
D08044
DB01275
DivK1c_000117
EC-000.1838
EINECS 201-680-3
Hidral
Hidral (TN)
Hidralazin
Hidralazina
Hidralazina [INN-Spanish]
Hidralazina [Spanish]
Hipoftalin
HLZ
Hydralazin
hydralazine
Hydralazine (INN)
Hydralazine [INN:BAN]
Hydralazine hydrochloride
Hydralazine mono hydrochloride
Hydralazine mono-hydrochloride
|
Hydralazinum
Hydralazinum [INN-Latin]
Hydrallazin
Hydrallazine
Hydrazinophthalazine
Hydrazone 1(2H)-phthalazinone
Hydrochloride, hydralazine
Hypophthalin
IDI1_000117
Idralazina
Idralazina [DCIT]
Idralazina [Italian]
InChI=1/C8H8N4/c9-11-8-7-4-2-1-3-6(7)5-10-12-8/h1-5H,9H2,(H,11,12)
KBio1_000117
KBio2_001355
KBio2_003923
KBio2_006491
KBio3_001350
KBioGR_000349
KBioSS_001355
Lopac0_000593
Lopac-H-1753
LS-109171
MolPort-000-876-738
MolPort-001-794-088
mono-Hydrochloride, hydralazine
NCGC00015501-01
NCGC00015501-02
NCGC00015501-05
NCGC00162199-01
NCIOpen2_001484
Nepresol
NINDS_000117
NSC 126699
NSC126699
Oprea1_207681
Oprea1_416878
phthalazin-1-ylhydrazine
Phthalazin-1-ylhydrazine
Praparat 5968
Prestwick0_000169
Prestwick1_000169
Prestwick2_000169
SPBio_000977
SPBio_001958
Spectrum_000875
Spectrum2_000969
Spectrum3_000455
Spectrum4_000005
Spectrum5_000822
ST50512087
UNII-26NAK24LS8
WLN: T66 CNNJ BMZ
ZINC12360535
|
|
| 36 |
|
Benidipine |
Approved, Investigational |
Phase 4 |
|
105979-17-7 |
|
| 37 |
|
Indapamide |
Approved |
Phase 4,Phase 3 |
|
26807-65-8 |
3702
|
|
Synonyms:
1-(4-Chloro-3-sulfamoylbenzamido)-2-methylindoline
26807-65-8
3-(Aminosulfonyl)-4-chloro-N-(2,3-dihydro-2-methyl-1H-indol-1-yl)benzamide
49564-58-1
4-Chloro-N-(2-methyl-1-indolinyl)-3-sulfamoylbenzamide
4-chloro-N-(2-methyl-2,3-dihydroindol-1-yl)-3-sulfamoylbenzamide
5-20-06-00348 (Beilstein Handbook Reference)
AB00052021
AC1L1GIW
AC-2073
Apo-Indapamide
Arifon
Bajaten
Benzamide, 3-(aminosulfonyl)-4-chloro-N-(2,3-dihydro-2-methyl-1H-indol-1-yl)- (9CI)
BPBio1_000263
BRD-A95869247-001-04-6
BRN 1604026
BSPBio_000239
BSPBio_002174
CHEMBL406
CID3702
Cormil
CPD000058829
D00345
Damide
DB00808
DivK1c_000508
EINECS 248-012-7
Fludex
HMS1920F19
HMS2090M16
HMS2091N07
HMS501J10
I01-0369
I0730
I1887_FLUKA
I1887_SIGMA
Idapamide
IDI1_000508
Indaflex
Indamol
Indapamid
Indapamida
Indapamida [INN-Spanish]
indapamide
Indapamide
Indapamide (JAN/USP)
Indapamide (USP)
Indapamide [USAN:INN:BAN:JAN]
Indapamidum
Indapamidum [INN-Latin]
Ipamix
|
KBio1_000508
KBio2_001397
KBio2_003965
KBio2_006533
KBio3_001394
KBioGR_000393
KBioSS_001397
Lozide
Lozol
Lozol (TN)
LS-26138
Metindamide
MLS000028554
MLS001148152
MLS002222229
MolPort-003-666-209
N-(4-Chloro-3-sulfamoylbenzamido)-2-methylindoline
N-[4-Chloro-3-sulfamoylbenzamido]-2- methylindoline
Natrilix
Natrix
Natrix (TN)
NCGC00089727-02
NCGC00089727-03
NINDS_000508
NLozol, Arifon, Fludex, Noranat, Veroxil, Tertensif, Indapamide
Noranat
Novo-Indapamide
Nu-Indapamide
Pressurai
Prestwick3_000220
RHC 2555
S-1520
S1730_Selleck
SAM002564214
SE 1520
SE-1520
SMR000058829
SPBio_001019
Spectrum_000917
SPECTRUM1500349
Spectrum2_000980
Spectrum3_000467
Spectrum4_000017
Spectrum5_000866
ST51015024
Tandix
Tertensif
TL8002131
UNII-F089I0511L
USV 2555
Veroxil
|
|
| 38 |
|
Quinapril |
Approved, Investigational |
Phase 4 |
|
85441-61-8 |
54892
|
|
Synonyms:
(3S)-2-(N-{(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}-L-alanyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
(3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid
(3S)-2-{(2S)-2-[(1S)-1-ethoxycarbonyl-3-phenylpropylamino]propanoyl}-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
(3S)-2-{N-((S)-1-Ethoxycarbonyl-3-phenylpropyl)-L-alanyl}-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
[3S-[2[R*(R*)],3R*]]-2-[2-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-3-Isoquinolinecarboxylic acid
2-(2-((1-(Ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid
85441-61-8
AB1004863
AC1L1HXL
AC1Q63IE
Accupril
Accuprin
Accupro
Acequin
Acuitel
BIDD:GT0797
BRD-K72222507-003-03-6
BSPBio_003022
C07398
C25H30N2O5
CHEBI:8713
CHEMBL1592
CID54892
D03752
DB00881
DivK1c_000710
Ectren
HMS2090L05
HMS502D12
IDI1_000710
KBio1_000710
|
KBio2_002077
KBio2_004645
KBio2_007213
KBio3_002522
KBioGR_000994
KBioSS_002077
Korec
Koretic
LS-177872
MolPort-003-987-265
NCGC00167962-01
NCGC00167962-02
NINDS_000710
quinapril
Quinapril (USP/INN)
Quinapril [INN:BAN]
Quinapril Hcl
QUINAPRIL HCL
Quinapril hydrochloride
Quinapril Hydrochloride
Quinaprilum
Quinaprilum [Latin]
Quinazil
SPBio_000749
Spectrum_001597
Spectrum2_000825
Spectrum3_001551
Spectrum4_000727
Spectrum5_001075
TL8005458
UNII-RJ84Y44811
|
|
| 39 |
|
Spirapril |
Approved |
Phase 4 |
|
83647-97-6 |
5311447
|
|
Synonyms:
(2S)-3-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,9-dithia-3-azaspiro[4.4]nonane-2-carboxylic acid
83647-97-6
AC1NSKNL
BRN 4277924
C22H30N2O5S2
CHEBI:101967
CHEMBL431
CID5311447
D08529
DB01348
Espirapril [Spanish]
LS-63095
Not established
|
Quadropril
Renormax
Renpress
Sandopril
Sch-33844
Setrilan
Spirapril
Spirapril (INN)
Spirapril [INN:BAN]
Spirapril hydrochloride
Spiraprilum [Latin]
TI-211-950
|
|
| 40 |
|
Manidipine |
Approved, Investigational |
Phase 4 |
|
89226-50-6 |
|
| 41 |
|
Folic Acid |
Approved, Nutraceutical, Vet_approved |
Phase 4,Phase 2,Phase 3,Phase 1 |
|
59-30-3 |
6037
|
|
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
AI3-26387
AKOS000503224
Antianemia factor
Apo-Folic
ARONIS014410
b9, Vitamin
BIDD:ER0563
BIDD:GT0641
BIF0608
bmse000299
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat b activ
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
Facid
Factor U
FOL
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
folic acid
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folic acid, (D)-isomer
Folic acid, (DL)-isomer
Folic acid, calcium salt (1:1)
Folic acid, monopotassium salt
Folic acid, monosodium salt
Folic acid, potassium salt
Folic acid, sodium salt
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
|
Folina (Italy)
Folipac
Folsaeure
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
Incafolic
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
Liver lactobacillus casei factor
Liver Lactobacillus casei factor
LS-2157
Millafol
Mission prenatal
Mittafol
MLS001304016
MLS001335861
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamate
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-amino-3,4-dihydro-4-oxo-6-Pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
nchembio.108-comp10
Nifolin
Nifolin [Denmark]
NINDS_000494
Novofolacid
Novofolacid [Canada]
N-Pteroyl-L-glutamate
N-Pteroyl-L-glutamic acid
NSC 3073
PGA
PGA (VAN)
Prestwick_230
Prestwick3_000627
PteGlu
Pteroylglutamate
Pteroylglutamic acid
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
Serum Folate Level
SMP2_000137
SMR000471860
SPBio_001357
Spectrum_001381
SPECTRUM1502020
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin b9
Vitamin B9
Vitamin Bc
Vitamin BC
Vitamin be
Vitamin Be
Vitamin m
Vitamin M
|
|
| 42 |
|
leucovorin |
Approved, Nutraceutical |
Phase 4,Phase 2,Phase 3 |
|
58-05-9 |
143
6006
|
|
Synonyms:
(5-formyl-5,6,7,8-tetrahydropteroyl)glutamate
(6R,S)-5-Formyltetrahydrofolate
10-Formyl-7,8-dihydrofolate
10-Formyl-7,8-dihydrofolic acid
5 Formyltetrahydrofolate
5 Formyltetrahydropteroylglutamate
5-Formyl-5,6,7,8-tetrahydrofolate
5-Formyl-5,6,7,8-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid
5-Formyltetrahydrofolate
5-formyltetrahydrofolic acid
5-Formyltetrahydrofolic acid
5-Formyltetrahydropteroylglutamate
5-Formyltetrahydropteroylglutamic acid
Acid, folinic
Acide folinique
Calcium citrovorum factor
Calcium folinate
Calcium leucovorin
Citrovorum factor
Factor, citrovorum
folinate
Folinate
Folinate, calcium
Folinic acid
Folinic acid calcium salt
Folinic acid calcium salt USP27
Folinic acid SF
Folinic acid-SF
L(-)-5-Formyl-5,6,7,8-tetrahydrofolate
|
L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid
Leucal
Leucovorin
Leucovorin calcium
Leucovorin folinic acid
Leucovorin, (D)-isomer
Leucovorin, (DL)-isomer
Leucovorin, (R)-isomer
Leucovorin, calcium
Leucovorin, calcium (1:1) salt
Leucovorin, calcium (1:1) salt, (DL)-isomer
Leucovorin, calcium (1:1) salt, pentahydrate
Leucovorin, monosodium salt
Leucovorinum
Leukovorin
Leukovorum
Levoleucovorin
L-leucovorin
L-Leucovorin
L-N-[P-[[(2-amino-5-Formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]-glutamic acid
Monosodium salt leucovorin
N(5)-Formyltetrahydrofolate
N-(5-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid
N5-Formyl-5,6,7,8-tetrahydrofolate
N5-Formyl-5,6,7,8-tetrahydrofolic acid
N5-Formyltetrahydrofolate
N5-Formyltetrahydrofolic acid
Rescuvolin
Welcovorin
Wellcovorin
|
|
| 43 |
|
Serine |
Approved, Nutraceutical |
Phase 4,Not Applicable |
|
56-45-1 |
5951
|
|
Synonyms:
(-)-Serine
(2S)-2-amino-3-Hydroxypropanoate
(2S)-2-amino-3-Hydroxypropanoic acid
(S)-(-)-Serine
(S)-2-amino-3-Hydroxypropanoate
(S)-2-amino-3-Hydroxy-propanoate
(S)-2-amino-3-Hydroxypropanoic acid
(S)-2-amino-3-Hydroxy-propanoic acid
(S)-2-Amino-3-hydroxypropanoic acid
(S)-a-amino-b-Hydroxypropionate
(S)-a-amino-b-Hydroxypropionic acid
(S)-alpha-amino-beta-Hydroxypropionate
(S)-alpha-amino-beta-Hydroxypropionic acid
(S)-b-amino-3-Hydroxypropionate
(S)-b-amino-3-Hydroxypropionic acid
(S)-beta-amino-3-Hydroxypropionate
(S)-beta-amino-3-Hydroxypropionic acid
(S)-Serine
(S)-α-amino-β-hydroxypropionate
(S)-α-amino-β-hydroxypropionic acid
2-amino-3-Hydroxypropanoate
2-amino-3-Hydroxypropanoic acid
3-Hydroxy-L-alanine
|
alpha-Amino-beta-hydroxypropionic acid
beta-Hydroxyalanine
beta-Hydroxy-L-alanine
b-Hydroxyalanine
b-Hydroxy-L-alanine
L Serine
L-(-)-Serine
L-2-amino-3-Hydroxypropionate
L-2-amino-3-Hydroxypropionic acid
L-3-Hydroxy-2-aminopropionate
L-3-Hydroxy-2-aminopropionic acid
L-3-Hydroxy-alanine
L-Ser
L-Serin
L-Serine
S
Ser
Serina
SERINE
Serinum
β-hydroxyalanine
β-hydroxy-L-alanine
|
|
| 44 |
|
tannic acid |
Approved, Nutraceutical |
Phase 4,Phase 3 |
|
|
|
| 45 |
|
Niacin |
Approved, Investigational, Nutraceutical |
Phase 4,Phase 3,Phase 2,Phase 1 |
|
59-67-6 |
938
|
|
Synonyms:
3 Pyridinecarboxylic acid
3-Carboxylpyridine
3-carboxypyridine
3-Carboxypyridine
3-Pyridinecarboxylate
3-Pyridinecarboxylic acid
3-Pyridylcarboxylate
3-Pyridylcarboxylic acid
Acide nicotinique
Acide Nicotinique
acido Nicotinico
Acido nicotinico
Acidum nicotinicum
Acidum Nicotinicum
Akotin
Aluminum salt, niacin
Anti-pellagra vitamin
Apelagrin
beta-Pyridinecarboxylate
beta-Pyridinecarboxylic acid
b-Pyridinecarboxylate
b-Pyridinecarboxylic acid
Daskil
Efacin
Enduracin
Hydrochloride, niacin
Induracin
Linic
Lithium nicotinate
m-Pyridinecarboxylate
m-Pyridinecarboxylic acid
M-Pyridinecarboxylic Acid
Niac
Niacin
Niacin aluminum salt
Niacin ammonium salt
Niacin calcium salt
Niacin cobalt (2+) salt
Niacin copper (2+) salt
Niacin hydrochloride
Niacin iron (2+) salt
Niacin lithium salt
Niacin lithium salt, hemihydrate
Niacin magnesium salt
Niacin manganese (2+) salt
Niacin potassium salt
Niacin sodium salt
|
Niacin tartrate
Niacin tosylate
Niacin zinc salt
Niacine
Niacor
Nicacid
Nicamin
Nicangin
nico 400
nico-400
Nico400
Nicobid
Nicocap
Nicodelmine
Nicolar
Niconacid
Nicosan 3
nico-Span
Nicotinate
Nicotinate, lithium
Nicotinic Acid
Nicotinipca
Nicyl
Nikotinsaeure
Nyclin
P.P. factor
Pellagra preventive factor
Pellagrin
Pelonin
Potassium salt, niacin
PP Factor
Pyridine-b-carboxylate
Pyridine-b-carboxylic acid
Pyridine-beta-carboxylate
Pyridine-beta-carboxylic acid
Pyridine-β-carboxylate
pyridine-β-carboxylic acid
Pyridine-β-carboxylic acid
slo-Niacin
Sodium salt, niacin
Tartrate, niacin
Tosylate, niacin
Vitamin b3
Vitamin B3
Wampocap
β-pyridinecarboxylate
β-pyridinecarboxylic acid
|
|
| 46 |
|
Nicotinamide |
Approved, Investigational, Nutraceutical |
Phase 4,Phase 3,Phase 2,Phase 1 |
|
98-92-0 |
936
|
|
Synonyms:
.beta.-Pyridinecarboxamide
11032-50-1
123574-63-0
1yc5
3 Pyridinecarboxamide
37321-14-5
3-Carbamoylpyridine
3-Pyridinecarboxamide
3-Pyridinecarboxylic acid amide
47865U_SUPELCO
55600-01-6
63748-44-7
72340_FLUKA
72340_SIGMA
72347_FLUKA
78731-47-2
98-92-0
A186B02E-6C70-4E54-9739-79398D439AAA
AC1L1ACZ
AC1Q4ZFV
AC-907/25014114
Acid amide
AI3-02906
Amid kyseliny nikotinove
Amid kyseliny nikotinove [Czech]
Amide PP
Aminicotin
Amixicotyn
Amnicotin
Astra brand OF niacinamide
Astra Brand of Niacinamide
Austrovit PP
b 3, Vitamin
B 3, Vitamin
b3, Vitamin
B3, Vitamin
BB_NC-2290
Benicot
beta-Pyridinecarboxamide
bmse000281
b-Pyridinecarboxamide
C00153
C6H6N2O
CCRIS 1901
CHEBI:17154
CHEMBL1140
CID936
CPD000058212
D00036
D009536
DB02701
DEA No. 1405
Delonin amide
Dipegyl
Dipigyl
EINECS 202-713-4
EINECS 234-265-0
Endobion
Enduramide
Factor pp
Factor PP
Hansamid
HMS2052M21
HMS2090B05
HMS2093H03
HSDB 1237
I02-1741
I02-2250
InChI=1/C6H6N2O/c7-6(9)5-2-1-3-8-4-5/h1-4H,(H2,7,9
Inovitan PP
Jenapharm brand OF niacinamide
Jenapharm Brand of Niacinamide
Jenapharm, Nicotinsaureamid
Jenapharm, nicotinsäureamid
LS-2051
m-(Aminocarbonyl)pyridine
Mediatric
Merck brand OF niacinamide
Merck Brand of Niacinamide
MLS000069714
MolMap_000061
MolPort-001-783-876
N0078
N0636_SIGMA
N2142_SIGMA
N3376_SIGMA
N5535_SIAL
NAM
Nandervit-N
NCGC00093354-03
NCGC00093354-04
nchembio.154-comp4
nchembio.73-comp6
Niacevit
Niacin
niacin - Vitamin B3
niacinamide
Niacinamide
Niacinamide (USP)
Niacinamide [USAN]
|
Niacinamide astra brand
Niacinamide Astra Brand
Niacinamide jenapharm brand
Niacinamide Jenapharm Brand
Niacinamide merck brand
Niacinamide Merck Brand
Niacinamide pharmagenix brand
Niacinamide Pharmagenix Brand
Niacinamide, Nicotinic acid amide, Nicotinamide
Niacotinamide
Niamide
Niavit PP
Nicamide
Nicamina
Nicamindon
Nicasir
Nicobion
Nicofort
Nicogen
Nicomidol
Nicosan 2
Nicosylamide
Nicota
Nicotamide
Nicotilamide
Nicotililamido
Nicotinamid
Nicotinamida
Nicotinamida [INN-Spanish]
nicotinamide
Nicotinamide
Nicotinamide (JP15/INN)
Nicotinamide (Niacinamide)
Nicotinamide, niacin, vitamin B3
Nicotinamide-carbonyl-14C
Nicotinamidum
Nicotinamidum [INN-Latin]
Nicotinate amide
Nicotine acid amide
Nicotine amide
Nicotinic acid amide
Nicotinic amide
Nicotinsaeureamid
Nicotinsaureamid
Nicotinsaureamid [German]
Nicotinsaureamid Jenapharm
Nicotinsäureamid jenapharm
Nicotol
Nicotylamide
Nicotylamidum
Nicovel
Nicovit
Nicovitina
Nicovitol
Nicozymin
Nictoamide
Nikasan
Nikazan
niko-Tamin
Niko-tamin
Nikotinamid
Nikotinsaeureamid
Nikotinsaeureamid [German]
Niocinamide
Niozymin
NSC 13128
NSC13128
NSC27452
Papulex
Pelmin
Pelmine
Pelonin amide
Pharmagenix brand OF niacinamide
Pharmagenix Brand of Niacinamide
PP-Faktor
Propamine a
pyridine-3-carboxamide
Pyridine-3-carboxylic acid amide
S1899_Selleck
SAM001246860
Savacotyl
SGCUT00176
SMR000058212
to_000073
UNII-25X51I8RD4
Vi-nicotyl
Vi-Nicotyl
Vi-noctyl
Vitamin B
Vitamin B (VAN)
Vitamin b 3
Vitamin B 3
Vitamin b3
Vitamin H1
vitamin PP
Vitamin PP
Witamina PP
WLN: T6NJ CVZ
ZINC00005878
β-pyridinecarboxamide
|
|
| 47 |
|
Tomato |
Approved, Nutraceutical |
Phase 4 |
|
|
|
| 48 |
|
Candesartan |
Experimental |
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
139481-59-7 |
2541
|
|
Synonyms:
139481-59-7
2-(ethyloxy)-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid
2-ethoxy-1-({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl)-1H-benzimidazole-7-carboxylic acid
2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylate
2-ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid
2-Ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid
2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid
2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4Ethyl]}-1H-benzimidazole-7-carboxylate
2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4Ethyl]}-1H-benzimidazole-7-carboxylic acid
2-ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl}-1H-benzimidazole-7-carboxylic acid
2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate
2-ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid
2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid
2-Ethoxy-3-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl] methyl]-3H-benzoimidazole-4-carboxylic acid
2-ethoxy-3-[[4-[2-(1h-tetrazol-5-yl)phenyl]phenyl]methyl]-3h-benzoimidazole-4-carboxylic acid
2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid
2-ethoxy-7-carboxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methylbenzimidazole
2-Ethoxy-7-carboxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methylbenzimidazole
AC1L1DWT
AC-203
Amias
Atacand
Atacand, Blopress, Amias, Ratacand,Candesartan
BIDD:GT0350
Blopress
Blopress (TN)
C07468
C081643
C24H20N6O3
|
candesartan
Candesartan (USAN/INN)
Candesartan [BAN]
Candesartan [USAN:INN]
Candesartan cilexetil
CHEBI:216848
CHEBI:3347
CHEMBL1016
CID2541
CV 11974
CV11974
CV-11974
D00522
DB00796
FT-0083585
HMS2089M22
HSDB 7520
I01-0374
KS-5003
L000156
LS-32740
MolPort-003-845-570
MolPort-005-943-739
NCGC00167474-01
Ratacand
S1578_Selleck
TL8000897
UNII-S8Q36MD2XX
|
|
| 49 |
|
Maleic acid |
Experimental |
Phase 4 |
|
110-16-7 |
444266
|
|
Synonyms:
(2E)-2-Butenedioate
(2E)-2-Butenedioic acid
(2E)-But-2-enedioate
(2E)-But-2-enedioic acid
(e)-2-Butenedioate
(e)-2-Butenedioic acid
2-(e)-Butenedioate
2-(e)-Butenedioic acid
Allomaleate
Allomaleic acid
Ammonium fumarate
Boletate
Boletic acid
e297
FC 33
|
Fumarate
Fumarsaeure
Furamag
Lichenate
Lichenic acid
Magnesium fumarate
Sodium fumarate
trans-1,2-Ethylenedicarboxylate
trans-1,2-Ethylenedicarboxylic acid
trans-2-Butenedioate
trans-2-Butenedioic acid
trans-But-2-enedioate
trans-But-2-enedioic acid
trans-Butenedioate
trans-Butenedioic acid
|
|
| 50 |
|
Canrenone |
Investigational |
Phase 4 |
|
976-71-6 |
13789
|
|
Synonyms:
17a-(2-Carboxyethyl)-17b-hydroxyandrosta-4,6-dien-3-one lactone
17b-Hydroxy-3-oxopregna-4,6-diene-21-carboxylic acid
17-Hydroxy-3-oxo-17a-pregna-4,6-diene-21-carboxylic acid g-lactone
17-Hydroxy-3-oxo-17a-pregna-4,6-diene-21-carboxylic acid lactone
20-Spiroxa-4,6-diene-3,21-dione
3-(17b-Hydroxy-3-oxoandrosta-4,6-dien-17a-yl)propionic acid g-lactone
3-(17b-Hydroxy-3-oxoandrosta-4,6-dien-17a-yl)propionic acid lactone
|
3-(3-oxo-17b-Hydroxy-4,6-androstadien-17a-yl)propionic acid g-lactone
3'-(3-oxo-17b-Hydroxyandrosta-4,6-dien-17a-yl)-propionic acid lactone
Aldadiene
Phanurane
R.P., 11614
SC-9376Canrenone
|
|
Interventional clinical trials:
(show top 50)
(show all 563)
| # |
Name |
Status |
NCT ID |
Phase |
Drugs |
| 1 |
Safety and Efficacy of Ramipril in the Treatment of Essential Hypertension |
Unknown status |
NCT00366119
|
Phase 4 |
Ramipril |
| 2 |
GRK4 Polymorphisms Blood Pressure Response to Candesartan |
Unknown status |
NCT01629225
|
Phase 4 |
Candesartan |
| 3 |
A Study of Nifecardia SRFC and Adalat OROS in the Treatment of Patients With Essential Hypertension |
Unknown status |
NCT00173667
|
Phase 4 |
Nifedipine 30 mg GITS |
| 4 |
BRAVE Study With Uncontrolled Essential Hypertension (BRAVE Study) |
Unknown status |
NCT02398929
|
Phase 4 |
Bisoprolol 2.5 mg;Placebo |
| 5 |
Effect of Nifedipine GITS in Patients With Mild-to-moderate Primary Hypertension |
Unknown status |
NCT02641821
|
Phase 4 |
Nifedipine GITS |
| 6 |
Effects of Angiotensin II Receptor Blocker Compared With Diuretics in High-risk Hypertensive Patients |
Unknown status |
NCT01011660
|
Phase 4 |
Amlodipine, Telmisartan, Amiloride Compound , Simvastatin |
| 7 |
Combined Antihypertensive Therapy and Sexual Dysfunction |
Unknown status |
NCT01238705
|
Phase 4 |
Felodipine add Irbesartan;Felodipine add Metoprolol |
| 8 |
Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Early Morning Blood Pressure and Central Arterial Pressure |
Unknown status |
NCT02357615
|
Phase 4 |
nifedipine CR tablets (Xin Ran);Adalat |
| 9 |
Treatment of HYpertension: Morning Versus Evening |
Unknown status |
NCT02214498
|
Phase 4 |
Enalapril/hydrochlorothiazide;Placebo |
| 10 |
Home Blood Pressure in Hypertension Management |
Unknown status |
NCT00841308
|
Phase 4 |
|
| 11 |
Valsartan and Amlodipine Compared to Losartan and Amlodipine in Hypertensive Patients |
Unknown status |
NCT00716950
|
Phase 4 |
valsartan/amlodpine;losartan/amlodpine |
| 12 |
Dose Titration of Lisinopril in Children Aged 1 to 18 Years With Primary or Secondary Hypertension |
Unknown status |
NCT02184858
|
Phase 4 |
lisinopril, ACE-inhibitor |
| 13 |
Danshen Dropping Pill for Coronary Heart Disease Heart and Artery Structure and Function |
Unknown status |
NCT01825759
|
Phase 4 |
danshen dripping pill |
| 14 |
Monotherapy Versus Dual Therapy for Initial Treatment for Hypertension |
Unknown status |
NCT00994617
|
Phase 4 |
Losartan and hydrochlorothiazide;Hydrochlorothiazide switched over with Losartan at 8 weeks |
| 15 |
L-arginine Treatment in Mild Hypertension |
Unknown status |
NCT02894723
|
Phase 4 |
|
| 16 |
Losartan and Simvastatin in Hypertensive Obeses With Liver Steatosis |
Unknown status |
NCT00669435
|
Phase 4 |
Losartan + Simvastatin;Amlodipine + Simvastatin |
| 17 |
Effects of Valsartan and Aliskiren on Hemostatic Indices in Hypertensive Diabetics |
Unknown status |
NCT01095822
|
Phase 4 |
Aliskiren + Valsartan |
| 18 |
Renal Denervation in Hypertension |
Unknown status |
NCT01570777
|
Phase 4 |
|
| 19 |
Efficacy and Safety of Levamlodipine Besylate Compared to Amlodipine Maleate in Patients With Essential Hypertension |
Completed |
NCT01131546
|
Phase 4 |
Levamlodipine besylate;Amlodipine maleate |
| 20 |
Canrenone as Add-on in Patients With Essential Hypertension |
Completed |
NCT02687178
|
Phase 4 |
Canrenone 50 vs canrenone 100 mg |
| 21 |
Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Mild to Moderate Essential Hypertension |
Completed |
NCT02031861
|
Phase 4 |
nifedipine CR tablets (Xin Ran);nifedipine CR tablets (Adalat) |
| 22 |
The Effect of Eprosartan on Hormones and Kidney Function in Patients With Essential Hypertension |
Completed |
NCT00438945
|
Phase 4 |
Eprosartan |
| 23 |
A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-R |
Completed |
NCT02079805
|
Phase 4 |
Azilsartan;Telmisartan |
| 24 |
Azilsartan Medoxomil in the Treatment of Essential Hypertension and Type 2 Diabetes in Asia |
Completed |
NCT02517866
|
Phase 4 |
Azilsartan Medoxomil |
| 25 |
Intensive Vasodilator Therapy in Patients With Essential Hypertension |
Completed |
NCT01180413
|
Phase 4 |
Amlodipine;Ramipril;Lercanidipine;Losartan |
| 26 |
Effects of Bisoprolol and Atenolol on Sympathetic Nervous Activity and Central Aortic Pressure in Patients With Essential Hypertension |
Completed |
NCT01762436
|
Phase 4 |
bisoprolol;atenolol |
| 27 |
Efficacy and Safety of Olmesartan Medoxomil in Stage 1 and 2 Essential Hypertension |
Completed |
NCT00890591
|
Phase 4 |
olmesartan medoxomil + hydrochlorothiazide, if necessary + amlodipine, if necessary |
| 28 |
Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea |
Completed |
NCT00328965
|
Phase 4 |
Lacidipine |
| 29 |
Efficacy and Safety of Once Daily Dosing of Aliskiren (300 mg (qd) Once a Day) to Twice Daily Dosing of Aliskiren (150 mg (Bid) Twice a Day) in Treating Moderate Hypertension. |
Completed |
NCT00654875
|
Phase 4 |
Aliskiren;Placebo to Aliskiren |
| 30 |
A Study on Molecular Genetics of Drug Responsiveness in Essential Hypertension |
Completed |
NCT03276598
|
Phase 4 |
Amlodipine;Bisoprolol;Hydrochlorothiazide;Losartan;Placebo |
| 31 |
The Efficacy and Safety of OROSARTAN® Versus CODIOVAN® in Patients With Essential Hypertension Uncontrolled With Monotherapy |
Completed |
NCT02433119
|
Phase 4 |
OROSARTAN® 5/160mg;CODIOVAN® 160/12.5mg |
| 32 |
A Randomized Controlled Study to Assess the Effects of Bisoprolol and Atenolol on Resting Heart Rate and Sympathetic Nervous System's Activity in Subjects With Essential Hypertension |
Completed |
NCT01251146
|
Phase 4 |
Bisoprolol;Atenolol |
| 33 |
A Study Evaluating the Gastrointestinal (GI) Safety and Tolerability of Aliskiren Compared to Ramipril in Essential Hypertension |
Completed |
NCT00631917
|
Phase 4 |
Aliskiren;Ramipril |
| 34 |
Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential Hypertension |
Completed |
NCT00130156
|
Phase 4 |
Bunazosin;Doxazosin;Valsartin |
| 35 |
Comparison of Awakening Versus Bedtime Dosing of Ramipril in Subjects With Essential Hypertension |
Completed |
NCT00473174
|
Phase 4 |
Ramipril |
| 36 |
Diuretics In the Management of Essential Hypertension (DIME) Study |
Completed |
NCT00131846
|
Phase 4 |
Thiazide diuretics;No diuretics |
| 37 |
A Study to Compare the Efficacy, Safety and Tolerability of Selomax With Its Individual Components |
Completed |
NCT00819104
|
Phase 4 |
Metoprolol XL 50mg + Amlodipine 5mg;Metoprolol XL 25 mg + Amlodipine 2.5mg;Metoprolol XL 50mg;Metoprolol XL 25 mg;Amlodipine 5mg |
| 38 |
A Study of Safety and Efficacy in MK-0954A Combination in Participants With Hypertension (MK-0954A-373 AM3) |
Completed |
NCT01431508
|
Phase 4 |
Losartan 50 mg / HCTZ 12.5 mg |
| 39 |
Efficacy and Safety of Metoprolol Succinate Prolonged-Release Tablet in Patients With Mild to Moderate Hypertension |
Completed |
NCT00861016
|
Phase 4 |
metoprolol succinate prolonged-release tablet and felodipine |
| 40 |
Study of Efficacy and Safety of CVAA489 in Hypertensive Patients |
Completed |
NCT02062645
|
Phase 4 |
amlodipine/valsartan |
| 41 |
Controlled Release Nifedipine and Valsartan Combination Therapy in Patients With Essential Hypertension |
Completed |
NCT01518855
|
Phase 4 |
Nifedipine (Adalat, BAYA1040);Amlodipine (Norvasc);Diovan |
| 42 |
Effectiveness of MICARDIS® (Telmisartan) on Blood Pressure Control and Quality of Live in Patients With Essential Hypertension |
Completed |
NCT02242370
|
Phase 4 |
Low dose of telmisartan;High dose of telmisartan |
| 43 |
Effect of the Fixed Dose Combination Amlodipine/Valsartan on Central Aortic Blood Pressure in Uncontrolled Essential Hypertension With Amlodipine 5 mg |
Completed |
NCT00687973
|
Phase 4 |
Valsartan/amlodipine 80/5 mg tablets;Amlodipine 5 mg capsules;Amlodipine 10 mg capsules;Atenolol 50 mg tablets;Atenolol 100 mg tablets |
| 44 |
Efficacy of Aliskiren Compared to Ramipril in the Treatment of Moderate Systolic Hypertensive Patients |
Completed |
NCT01042392
|
Phase 4 |
Aliskiren;Ramipril;Matching placebo to Aliskiren;Matching placebo to Ramipril |
| 45 |
China Stroke Primary Prevention Trial |
Completed |
NCT00794885
|
Phase 4 |
Enalapril/folic acid;Enalapril maleate |
| 46 |
Efficacy and Tolerability of an Aliskiren-based Treatment Algorithm in Patients With Mild to Moderate Hypertension |
Completed |
NCT00765947
|
Phase 4 |
Aliskiren;Hydrochlorothiazide;Amlodipine |
| 47 |
Hydrochlorothiazide (+) Losartan Potassium vs. Amlodipine Comparative Study (0954A-314) |
Completed |
NCT00157963
|
Phase 4 |
MK0954A; hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 12 weeks |
| 48 |
PMS Study of Amlodipine/Valsartan for the Treatment of Hypertension |
Completed |
NCT02058446
|
Phase 4 |
Amlodipine/Valsartan |
| 49 |
Hybrid Blood Pressure Monitor Validation |
Completed |
NCT01120990
|
Phase 4 |
|
| 50 |
Calcium Channel Blockers (CCBs) or Diuretics as an Add-on to Olmesartan Medoxomil in Hypertension |
Completed |
NCT00858702
|
Phase 4 |
olmesartan medoxomil and a CCB;olmesartan medoxomil and a diuretic |
Inferred drug relations via
UMLS
73
/
NDF-RT
51
:
|
